Header Logo

NICOLA HANANIA

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
Address1504 TAUB LOOP
Houston, TX 77030
vCardDownload vCard

    Collapse Biography 
    Collapse awards and honors
    2022Master Clinician Award, Baylor College of Medicine
    2016Elected Fellow of European Respiratory Society (FERS) , European Respiratory Society
    2016Thomas Petty, MD, Master ACCP Memorial Lecture in COPD, American College of Chest Physicians
    2013 - 2016Distinguished Scholar in Respiratory Health, American College of Chest Physicians
    2013 - 2014Member, ACCP/CTS Panel : Acute Exacerbations of COPD Guidelines, American College of Chest Physicians
    2011Member, ACP/ACCP/ATS/ERS Panel: Clinical Practice Guidelines of COPD, American College of Chest Physicians
    2011 - NowElected to "Best Doctors in America"
    2009Donald Robert McCaffree Humanitarian Award, American College of Chest Physicians
    2005 - 2009Career Investigator Award (K23), National Institute of Health, NHLBI
    2003Fulbright and Jaworski L.L.P. Faculty Excellence Award for Teaching and Evaluation, Baylor College of Medicine
    2003Attending of the Year Award, Pulmonary Section, Baylor College of Medicine
    2003Award for Excellence in Teaching, Department of Medicine, Baylor College of Medicine
    2003 - 2010Member, Academy of Distinguished Educators, , Baylor College of Medicine
    1995Listed in Marquis Who's Who in America, 50th Edition,
    1994The Toronto Hospital, Department of Medicine, Resident's Research Award (first prize), University of Toronto
    1994Dupont Pharmaceuticals / American College of Chest Physicians - Junior Investigator Award, American College of Chest Physicians
    1993The Toronto Hospital, Department of Medicine, Resident Research Award (third prize), University of Toronto
    1992University of Toronto, Department of Medicine, Research Award, University of Toronto

    Collapse Overview 
    Collapse overview
    Nicola (Nick) A. Hanania, MD, MS is Professor of Medicine in the Section of Pulmonary and Critical Care Medicine and Director of the Airways Clinical Research Center at the Baylor College of Medicine in Houston, Texas, USA. He is Chief of the Section of Pulmonary and Critical Care Medicine at Ben Taub Hospital in Houston. He completed his medical training at the University of Jordan followed by residency in internal medicine and a fellowship in pulmonary medicine at the University of Toronto, Canada. He subsequently completed a fellowship in critical care medicine at Baylor College of Medicine, where he later earned a master’s degree in clinical investigation.

    Dr. Hanania is a fellow of the Royal College of Physicians and Surgeons of Canada, The American College of Chest Physicians, the American College of Physicians and the European Respiratory Society. As a Fellow of the American College of Chest Physicians, Dr. Hanania has served on the Board of Regents and as Chair of the Clinical Pulmonary, Airways Networks and Council of Networks for this organization. He has been on the Board of Trustees of the Chest Foundation since 2012. In addition, he served as a member of the Health Policy Committee of the American Thoracic Societyand on several guideline and workshop panels including the ACP/ATS/ACCP/ERS Clinical Practice guidelines on COPD and the CTS/ACCP COPD exacerbations guidelines.

    Dr. Hanania has received multiple awards including the Master Clinician Award from Baylor College of Medicine and the Distinguished Scholar in Respiratory Health from the American College of Chest Physicians. He is editor-in-chief of Respiratory Medicine and is Associate Editor of Current Opinion in Pulmonary Medicine (Asthma Section) and Lung and member of Editorial Board of CHEST and Journal of COPD.

    Dr. Hanania’s research interests focus on the pharmacology and management of asthma and COPD. He has published more than 200 peer-reviewed papers, book chapters, editorials and reviews on these topics. He is actively involved in clinical trials investigating novel treatments. He is Principal Investigator for the American Lung Association Airway Clinical Research Center at Baylor College of Medicine, as well as Principal Investigator or Co-Investigator in several clinical trials in asthma and COPD. He has been invited and has lectured widely at local, regional, national and international meetings.

    Collapse Research 
    Collapse research activities and funding
    U01AI095050     (HANANIA, NICOLA A)Aug 15, 2011 - Jul 31, 2016
    NIH
    Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol in Mild Asthma
    Role: Principal Investigator
    K23HL079054     (HANANIA, NICOLA A)Sep 6, 2005 - Aug 31, 2009
    NIH
    Response to Beta2-Agonists in Acute Severe Asthma
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ruvuna L, Hijazi K, Guzman DE, Guo C, Loureiro J, Khokhlovich E, Morris M, Obeidat M, Pratte KA, DiLillo KM, Sharma S, Kechris K, Anzueto A, Barjaktarevic I, Bleecker ER, Casaburi R, Comellas A, Cooper CB, DeMeo DL, Foreman M, Flenaugh EL, Han MK, Hanania NA, Hersh CP, Krishnan JA, Labaki WW, Martinez FJ, O'Neal WK, Paine R, Peters SP, Woodruff PG, Wells JM, Wendt CH, Arnold KB, Barr RG, Curtis JL, Ngo D, Bowler RP, SPIROMICS, COPDGene and MESA-Lung Investigators. Dynamic and prognostic proteomic associations with FEV1 decline in chronic obstructive pulmonary disease. medRxiv. 2024 Aug 08. PMID: 39148837; PMCID: PMC11326337.
      Citations:    
    2. Adrish M, Hanania NA. POINT: Should Triple Inhaled Therapy Be Considered in All Patients With Group E COPD? Yes. Chest. 2024 Jul; 166(1):12-17. PMID: 38986633.
      Citations:    Fields:    Translation:Humans
    3. Adrish M, Hanania NA. Rebuttal From Drs Adrish and Hanania. Chest. 2024 Jul; 166(1):20-21. PMID: 38986636.
      Citations:    Fields:    
    4. Oppenheimer J, Kerstjens HA, Boulet LP, Hanania NA, Kerwin E, Moore A, Nathan RA, Peachey G, Pizzichini E, Slade D, Zarankaite A, Pavord ID. Characterization of Moderate and Severe Asthma Exacerbations in the CAPTAIN Study. J Allergy Clin Immunol Pract. 2024 Sep; 12(9):2372-2380.e5. PMID: 38777124.
      Citations:    Fields:    
    5. Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Patel N, Yancopoulos GD, Akinlade B, Maloney J, Lu X, Bauer D, Bansal A, Abdulai RM, Robinson LB, NOTUS Study Investigators. Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation. N Engl J Med. 2024 Jun 27; 390(24):2274-2283. PMID: 38767614.
      Citations: 1     Fields:    Translation:HumansCellsCTClinical Trials
    6. Razjouyan J, Hanania NA, Nowakowski S, Agrawal R, Sharafkhaneh A. Identification of sleep phenotypes in COPD using machine learning-based cluster analysis. Respir Med. 2024 Jun; 227:107641. PMID: 38710399; PMCID: PMC11218872.
      Citations:    Fields:    Translation:Humans
    7. Yohannes AM, Casaburi R, Dryden S, Hanania NA. Sex differences and determinants of anxiety symptoms in patients with COPD initiating pulmonary rehabilitation. Respir Med. 2024 Jun; 227:107633. PMID: 38631527.
      Citations:    Fields:    Translation:Humans
    8. Wu TD, Hanania NA, Diamant Z. An Update on Patient-Reported Outcomes in Asthma. Chest. 2024 May; 165(5):1049-1057. PMID: 38365175.
      Citations: 1     Fields:    Translation:Humans
    9. Corren J, Szefler SJ, Sher E, Korenblat P, Soong W, Hanania NA, Berman G, Brusselle G, Zitnik R, Natalie CR, Sun L, Siu K, Wu WS, Lio P, Armstrong AW. Lebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-Defined Type 2 Population. J Allergy Clin Immunol Pract. 2024 May; 12(5):1215-1224.e3. PMID: 38360213.
      Citations: 1     Fields:    Translation:HumansCellsCTClinical Trials
    10. Matera MG, Calzetta L, Rogliani P, Hanania N, Cazzola M. Cardiovascular Events with the Use of Long-Acting Muscarinic Receptor Antagonists: An Analysis of the FAERS Database 2020-2023. Lung. 2024 Apr; 202(2):119-125. PMID: 38321329; PMCID: PMC11009752.
      Citations:    Fields:    Translation:Humans
    11. Chase NM, Littlejohn M, Holweg CTJ, Millette LA, Seetasith A, Steinke JW, Trzaskoma BL, Hanania NA, Casale TB. Effectiveness of omalizumab across different dosing regimens in patients with moderate-to-severe allergic asthma. Respir Med. 2024 Mar; 223:107537. PMID: 38253245.
      Citations:    Fields:    Translation:Humans
    12. Regan EA, Lowe ME, Make BJ, Curtis JL, Chen QG, Crooks JL, Wilson C, Oates GR, Gregg RW, Baldomero AK, Bhatt SP, Diaz AA, Benos PV, O'Brien JK, Young KA, Kinney GL, Conrad DJ, Lowe KE, DeMeo DL, Non A, Cho MH, Kallet J, Foreman MG, Westney GE, Hoth K, MacIntyre NR, Hanania NA, Wolfe A, Amaza H, Han M, Beaty TH, Hansel NN, McCormack MC, Balasubramanian A, Crapo JD, Silverman EK, Casaburi R, Wise RA. Early Evidence of Chronic Obstructive Pulmonary Disease Obscured by Race-Specific Prediction Equations. Am J Respir Crit Care Med. 2024 01 01; 209(1):59-69. PMID: 37611073; PMCID: PMC10870894.
      Citations: 2     Fields:    Translation:Humans
    13. Caminati M, Buhl R, Corren J, Hanania NA, Kim H, Korn S, Lommatzsch M, Martin N, Matucci A, Nasser SM, Pavord ID, Domingo C. Tezepelumab in patients with allergic and eosinophilic asthma. Allergy. 2024 05; 79(5):1134-1145. PMID: 38146651.
      Citations:    Fields:    
    14. Wallick C, To TM, Korom S, Masters H, Wu N, Moawad D, Hanania NA. Impact of antiviral therapy on short- and long-term outcomes of patients with chronic obstructive pulmonary disease after influenza infection. Influenza Other Respir Viruses. 2023 Dec; 17(12):e13231. PMID: 38098649; PMCID: PMC10719080.
      Citations:    Fields:    Translation:Humans
    15. Casale TB, Chipps BE, Iqbal A, Yoo B, Millette LA, Hanania NA. Influence of baseline bronchodilator reversibility and blood eosinophils on lung function in patients with asthma following omalizumab. J Allergy Clin Immunol Pract. 2024 02; 12(2):512-514.e2. PMID: 38070771.
      Citations:    Fields:    Translation:HumansCells
    16. Hanania NA, Settipane RA, Khoury S, Shaikh A, Dotiwala Z, Casciano J, Foggs MB. Adding tiotropium or long-acting ?2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization. Allergy Asthma Proc. 2023 11 13; 44(6):413-421. PMID: 37919843.
      Citations: 1     Fields:    Translation:Humans
    17. Silverman EK, Kim AY, Make BJ, Regan EA, Morrow JD, Hersh CP, O'Brien J, Crapo JD, Hansel NN, Criner G, Flenaugh EL, Conrad D, Casaburi R, Bowler RP, Hanania NA, Barr RG, Bhatt SP, Sciurba FC, Anzueto A, Han MK, McEvoy CE, Comellas AP, DeMeo DL, Rosiello R, Curtis JL, Uchida T, Wilson C, O'Rourke PP. Returning incidentally discovered Hepatitis C RNA-seq results to COPDGene study participants. NPJ Genom Med. 2023 Oct 31; 8(1):36. PMID: 37903807; PMCID: PMC10616181.
      Citations:    
    18. Rogers L, Jesenak M, Bjermer L, Hanania NA, Diamant Z, Seys SF. Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient. Respir Med. 2023 11; 218:107414. PMID: 37776915.
      Citations: 3     Fields:    Translation:Humans
    19. Corren J, Hanania NA, Busse WW, Sher LD, Altincatal A, Hardin M, Mannent LP, Amin N, Lederer DJ, Soler X, Jacob-Nara JA, Rowe PJ, Deniz Y. Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitization. Clin Exp Allergy. 2023 10; 53(10):1020-1030. PMID: 37752621.
      Citations:    Fields:    Translation:Humans
    20. Hanania NA. Guest Editor's bio: Dr. Nicola A. Hanania. Respir Med. 2023 11; 218:107405. PMID: 37683775.
      Citations:    Fields:    
    21. Adrish M, Hanania NA. Revisiting the Use of Antibiotics to Prevent COPD Exacerbation: Is Doxycycline the Answer? Am J Respir Crit Care Med. 2023 09 01; 208(5):509-511. PMID: 37531185; PMCID: PMC10492254.
      Citations:    Fields:    Translation:Humans
    22. Page CP, Hanania NA, Cazzola M, Matera MG, Rogliani P. Revisiting asthma pharmacotherapy: where do we stand and where do we want to go? Eur Respir J. 2023 08; 62(2). PMID: 37474159.
      Citations: 1     Fields:    Translation:Humans
    23. Cazzola M, Rogliani P, Barnes PJ, Blasi F, Celli B, Hanania NA, Martinez FJ, Miller BE, Miravitlles M, Page CP, Tal-Singer R, Matera MG. An Update on Outcomes for COPD Pharmacological Trials: A COPD Investigators Report - Reassessment of the 2008 American Thoracic Society/European Respiratory Society Statement on Outcomes for COPD Pharmacological Trials. Am J Respir Crit Care Med. 2023 08 15; 208(4):374-394. PMID: 37236628.
      Citations: 2     Fields:    Translation:Humans
    24. Assaf S, Stenberg H, Jesenak M, Tarasevych SP, Hanania NA, Diamant Z. Asthma in the era of COVID-19. Respir Med. 2023 11; 218:107373. PMID: 37567514.
      Citations:    Fields:    Translation:HumansCells
    25. Kerr M, Tarabichi Y, Evans A, Mapel D, Pace W, Carter V, Couper A, Drummond MB, Feigler N, Federman A, Gandhi H, Hanania NA, Kaplan A, Kostikas K, Kruszyk M, van Melle M, M?llerov? H, Murray R, Ohar J, Pollack M, Pullen R, Williams D, Wisnivesky J, Han MK, Meldrum C, Price D. Patterns of care in the management of high-risk COPD in the US (2011-2019): an observational study for the CONQUEST quality improvement program. Lancet Reg Health Am. 2023 Aug; 24:100546. PMID: 37545746; PMCID: PMC10400879.
      Citations: 1     
    26. Diamant Z, Jesenak M, Hanania NA, Heaney LG, Djukanovic R, Ryan D, Quirce S, Backer V, Gaga M, Pavord I, Antol?n-Am?rigo D, Assaf S, Bakakos P, Bobcakova A, Busse W, Kappen J, Loukides S, van Maaren M, Panzner P, Pite H, Spanevello A, Stenberg H, Striz I, Thio B, Vasakova MK, Conti D, Fokkens W, Lau S, Scadding GK, Van Staeyen E, Hellings PW, Bjermer L. EUFOREA pocket guide on the diagnosis and management of asthma: An educational and practical tool for general practitioners, non-respiratory physicians, paramedics and patients. Respir Med. 2023 11; 218:107361. PMID: 37517623.
      Citations:    Fields:    Translation:Humans
    27. Diamant Z, Seys SF, Rogers L, Hanania NA. Integrating innovations in asthma research into clinical practice. Respir Med. 2023 10; 217:107345. PMID: 37454981.
      Citations:    Fields:    Translation:Humans
    28. Cazzola M, Hanania NA, Page CP, Matera MG. Novel Anti-Inflammatory Approaches to COPD. Int J Chron Obstruct Pulmon Dis. 2023; 18:1333-1352. PMID: 37408603; PMCID: PMC10318108.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    29. Sagara H, Oppenheimer J, Hanania NA, Chaudhuri R, Bailes Z, Fowler A, Peachey G, Pizzichini E, Slade D. Clinic vs?Home Spirometry for Monitoring Lung Function in Patients With Asthma. Chest. 2023 11; 164(5):1087-1096. PMID: 37385337.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    30. Matera MG, Hanania NA, Maniscalco M, Cazzola M. Pharmacotherapies in Older Adults with COPD: Challenges and Opportunities. Drugs Aging. 2023 07; 40(7):605-619. PMID: 37316689; PMCID: PMC10300166.
      Citations: 2     Fields:    Translation:Humans
    31. Stolz D, Matera MG, Rogliani P, van den Berge M, Papakonstantinou E, Gosens R, Singh D, Hanania N, Cazzola M, Maitland-van der Zee AH, Fregonese L, Mathioudakis AG, Vestbo J, Rukhadze M, Page CP. Current and future developments in the pharmacology of asthma and COPD: ERS seminar, Naples 2022. Breathe (Sheff). 2023 Jun; 19(2):220267. PMID: 37377851; PMCID: PMC10292790.
      Citations: 1     
    32. Mohan A, Lugogo NL, Hanania NA, Reddel HK, Akuthota P, O'Byrne PM, Guilbert T, Papi A, Price D, Jenkins CR, Kraft M, Bacharier LB, Boulet LP, Yawn BP, Pleasants R, Lazarus SC, Beasley R, Gauvreau G, Israel E, Schneider-Futschik EK, Yorgancioglu A, Martinez F, Moore W, Sumino K. Questions in Mild Asthma: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2023 06 01; 207(11):e77-e96. PMID: 37260227; PMCID: PMC10263130.
      Citations: 3     Fields:    Translation:Humans
    33. Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Cole J, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Mannent LP, Patel N, Staudinger HW, Yancopoulos GD, Mortensen ER, Akinlade B, Maloney J, Lu X, Bauer D, Bansal A, Robinson LB, Abdulai RM, BOREAS Investigators. Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts. N Engl J Med. 2023 Jul 20; 389(3):205-214. PMID: 37272521.
      Citations: 30     Fields:    Translation:HumansCellsCTClinical Trials
    34. Striz I, Golebski K, Strizova Z, Loukides S, Bakakos P, Hanania NA, Jesenak M, Diamant Z. New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis. Clin Sci (Lond). 2023 05 18; 137(9):727-753. PMID: 37199256; PMCID: PMC10195992.
      Citations: 5     Fields:    Translation:Humans
    35. Regan EA, Lowe ME, Make BJ, Curtis JL, Chen QG, Cho MH, Crooks JL, Lowe KE, Wilson C, O'Brien JK, Oates GR, Baldomero AK, Kinney GL, Young KA, Diaz AA, Bhatt SP, McCormack MC, Hansel NN, Kim V, Richmond NE, Westney GE, Foreman MG, Conrad DJ, DeMeo DL, Hoth KF, Amaza H, Balasubramanian A, Kallet J, Watts S, Hanania NA, Hokanson J, Beaty TH, Crapo JD, Silverman EK, Casaburi R, Wise R. Use of the Spirometric "Fixed-Ratio" Underdiagnoses COPD in African-Americans in a Longitudinal Cohort Study. J Gen Intern Med. 2023 10; 38(13):2988-2997. PMID: 37072532; PMCID: PMC10593702.
      Citations:    Fields:    
    36. Murugesan N, Saxena D, Dileep A, Adrish M, Hanania NA. Update on the Role of FeNO in Asthma Management. Diagnostics (Basel). 2023 Apr 15; 13(8). PMID: 37189529; PMCID: PMC10137365.
      Citations: 4     
    37. Maspero JF, Bachert C, Martinez FJ, Hanania NA, Ortiz B, Patel N, Mannent LP, Praestgaard A, Pandit-Abid N, Siddiqui S, Hardin M. Clinical Efficacy among Patients with Chronic Rhinosinusitis with Nasal Polyps and Clinical Features of Obstructive Lung Disease: Post Hoc Analysis of the Phase III SINUS-24 and SINUS-52 Studies. J Asthma Allergy. 2023; 16:333-342. PMID: 37026112; PMCID: PMC10072142.
      Citations: 1     
    38. Hanania NA, Bunner SH, Bengtson LGS, Ismaila AS, Bogart M. COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA. Int J Chron Obstruct Pulmon Dis. 2023; 18:407-418. PMID: 36998390; PMCID: PMC10045302.
      Citations:    Fields:    Translation:Humans
    39. Adrish M, Hanania NA. Asthma and cardiovascular disease: A bidirectional association? Respirology. 2023 03; 28(3):217-219. PMID: 36750439.
      Citations:    Fields:    Translation:Humans
    40. Cazzola M, Rogliani P, Matera MG, Hanania NA. Cardiovascular disease in asthma patients: From mechanisms to therapeutic implications. Kardiol Pol. 2023; 81(3):232-241. PMID: 36739655.
      Citations: 1     Fields:    Translation:Humans
    41. Mintz M, Barjaktarevic I, Mahler DA, Make B, Skolnik N, Yawn B, Zeyzus-Johns B, Hanania NA. Reducing the Risk of Mortality in Chronic Obstructive Pulmonary Disease With Pharmacotherapy: A Narrative Review. Mayo Clin Proc. 2023 02; 98(2):301-315. PMID: 36737119.
      Citations: 1     Fields:    Translation:Humans
    42. Tran TV, Kinney GL, Comellas A, Hoth KF, Baldomero AK, Mamary AJ, Curtis JL, Hanania N, Casaburi R, Young KA, Kim V, Make B, Wan ES, Diaz AA, Hokanson J, Crapo JD, Silverman EK, Bhatt SP, Regan E, COPDGene? Investigators ? Core Units, COPDGene? Investigators ? Clinical Centers, Fortis S. Prevalence of abnormal spirometry in individuals with a smoking history and no known obstructive lung disease. Respir Med. 2023 03; 208:107126. PMID: 36717002; PMCID: PMC9990311.
      Citations:    Fields:    Translation:Humans
    43. Garner O, Hanania NA. Is Extracorporeal Membrane Oxygenation More Than Just Salvage Therapy in Acute Life-Threatening Asthma? Chest. 2023 01; 163(1):1-2. PMID: 36628661.
      Citations:    Fields:    Translation:Humans
    44. Brusselle G, Quirce S, Papi A, Kuna P, Chipps BE, Hanania NA, Blaiss M, Msihid J, Jacob-Nara JA, Deniz Y, Rowe PJ, Gall R, Ortiz B, Djandji M, Radwan A. Dupilumab Efficacy in Patients With Uncontrolled or Oral Corticosteroid-Dependent Allergic and Nonallergic Asthma. J Allergy Clin Immunol Pract. 2023 03; 11(3):873-884.e11. PMID: 36572184.
      Citations: 2     Fields:    Translation:Humans
    45. Agusti A, Ambrosino N, Blackstock F, Bourbeau J, Casaburi R, Celli B, Crouch R, Negro RD, Dreher M, Garvey C, Gerardi D, Goldstein R, Hanania N, Holland AE, Kaur A, Lareau S, Lindenauer PK, Mannino D, Make B, Maltais F, Marciniuk JD, Meek P, Morgan M, Pepin JL, Reardon JZ, Rochester C, Singh S, Spruit MA, Steiner MC, Troosters T, Vitacca M, Clini E, Jardim J, Nici L, Raskin J, ZuWallack R. COPD: Providing the right treatment for the right patient at the right time. Respir Med. 2023 02; 207:107041. PMID: 36610384.
      Citations:    Fields:    Translation:Humans
    46. Bardsley S, Criner GJ, Halpin DMG, Han MK, Hanania NA, Hill D, Lange P, Lipson DA, Martinez FJ, Midwinter D, Siler TM, Singh D, Wise RA, van Zyl-Smit RN, Berkman N. Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysis. Respir Med. 2022 12; 205:107040. PMID: 36470149.
      Citations: 1     Fields:    Translation:Humans
    47. Miller MJ, Cash-Goldwasser S, Marx GE, Schrodt CA, Kimball A, Padgett K, Noe RS, McCormick DW, Wong JM, Labuda SM, Borah BF, Zulu I, Asif A, Kaur G, McNicholl JM, Kourtis A, Tadros A, Reagan-Steiner S, Ritter JM, Yu Y, Yu P, Clinton R, Parker C, Click ES, Salzer JS, McCollum AM, Petersen B, Minhaj FS, Brown E, Fischer MP, Atmar RL, DiNardo AR, Xu Y, Brown C, Goodman JC, Holloman A, Gallardo J, Siatecka H, Huffman G, Powell J, Alapat P, Sarkar P, Hanania NA, Bruck O, Brass SD, Mehta A, Dretler AW, Feldpausch A, Pavlick J, Spencer H, Ghinai I, Black SR, Hernandez-Guarin LN, Won SY, Shankaran S, Simms AT, Alarc?n J, O'Shea JG, Brooks JT, McQuiston J, Honein MA, O'Connor SM, Chatham-Stephens K, O'Laughlin K, Rao AK, Raizes E, Gold JAW, Morris SB, CDC Severe Monkeypox Investigations Team. Severe Monkeypox in Hospitalized Patients - United States, August 10-October 10, 2022. MMWR Morb Mortal Wkly Rep. 2022 Nov 04; 71(44):1412-1417. PMID: 36327164; PMCID: PMC9639440.
      Citations: 35     Fields:    Translation:HumansPHPublic Health
    48. Hanania NA, Castro M, Bateman E, Pavord ID, Papi A, FitzGerald JM, Maspero JF, Katelaris CH, Singh D, Daizadeh N, Altincatal A, Pandit-Abid N, Soler X, Siddiqui S, Laws E, Jacob-Nara JA, Rowe PJ, Lederer DJ, Hardin M, Deniz Y. Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction. Ann Allergy Asthma Immunol. 2023 02; 130(2):206-214.e2. PMID: 36332763.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    49. Adrish M, Hanania NA. Choosing and switching biological agents in severe asthma. Respirology. 2022 11; 27(11):926-928. PMID: 36161677.
      Citations: 1     Fields:    Translation:Humans
    50. Hanania NA, Niven R, Chanez P, Antoine D, Pfister P, Garcia Conde L, Jaumont X. Long-term effectiveness and safety of omalizumab in pediatric and adult patients with moderate-to-severe inadequately controlled allergic asthma. World Allergy Organ J. 2022 Oct; 15(10):100695. PMID: 36254180; PMCID: PMC9519799.
      Citations: 3     
    51. COPDGene Investigators, Adviento BA, Regan EA, Make BJ, Han MK, Foreman MG, Iyer AS, Bhatt SP, Kim V, Bon J, Soler X, Kinney GL, Hanania NA, Lowe KE, Holm KE, Yohannes AM, Shinozaki G, Hoth KF, Fiedorowicz JG. Clinical Markers Associated With Risk of Suicide or Drug Overdose Among Individuals With?Smoking Exposure: A Longitudinal Follow-up Study of the COPDGene Cohort. Chest. 2023 02; 163(2):292-302. PMID: 36167120; PMCID: PMC10083129.
      Citations: 1     Fields:    Translation:Humans
    52. Boulet LP, Hanania NA. When Asthma and Chronic Obstructive Pulmonary Disease Overlap; Current Knowledge and Unmet Needs. Immunol Allergy Clin North Am. 2022 08; 42(3):499-505. PMID: 35965040.
      Citations:    
    53. Hanania NA, Miravitlles M. Pharmacologic Management Strategies of Asthma-Chronic Obstructive Pulmonary Disease Overlap. Immunol Allergy Clin North Am. 2022 08; 42(3):657-669. PMID: 35965052.
      Citations:    
    54. Hanania NA, Boulet LP. Asthma-Chronic Obstructive Pulmonary Disease: An Update. Immunol Allergy Clin North Am. 2022 08; 42(3):xiii-xiv. PMID: 35965055.
      Citations:    
    55. Adrish M, Anand MP, Hanania NA. Phenotypes of Asthma-Chronic Obstructive Pulmonary Disease Overlap. Immunol Allergy Clin North Am. 2022 08; 42(3):645-655. PMID: 35965051.
      Citations:    
    56. Hanania NA, Halpin DMG, Jackson DJ, Panettieri RA, Castro M, Daizadeh N, Gall R, Jacob-Nara JA, Ortiz B, Djandji M, Rowe PJ, Deniz Y, Maspero JF, Domingo C. Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma Exacerbation. J Asthma Allergy. 2022; 15:851-854. PMID: 35789920; PMCID: PMC9250327.
      Citations:    
    57. Yohannes AM, Murri MB, Hanania NA, Regan EA, Iyer A, Bhatt SP, Kim V, Kinney GL, Wise RA, Eakin MN, Hoth KF, COPDGene Investigators. Depressive and anxiety symptoms in patients with COPD: A network analysis. Respir Med. 2022 07; 198:106865. PMID: 35576775; PMCID: PMC10698756.
      Citations:    Fields:    Translation:Humans
    58. Yohannes AM, Casaburi R, Dryden S, Hanania NA. The effectiveness of pulmonary rehabilitation on chronic obstructive pulmonary disease patients with concurrent presence of comorbid depression and anxiety. Respir Med. 2022 06; 197:106850. PMID: 35427843.
      Citations:    Fields:    Translation:Humans
    59. Castro M, Hanania NA, Ford LB, Halpin DMG, Jackson DJ, Daizadeh N, Djandji M, Mitchell CP, Crikelair N, Jacob-Nara JA, Deniz Y, Rowe PJ, Ortiz B, Domingo C, Maspero JF. Dupilumab Efficacy in Steroid-Dependent Severe Asthma by Baseline Oral Corticosteroid Dose. J Allergy Clin Immunol Pract. 2022 07; 10(7):1835-1843. PMID: 35398549.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    60. Razjouyan J, Helmer DA, Lynch KE, Hanania NA, Klotman PE, Sharafkhaneh A, Amos CI. Smoking Status and Factors associated with COVID-19 In-Hospital Mortality among US Veterans. Nicotine Tob Res. 2022 03 26; 24(5):785-793. PMID: 34693967; PMCID: PMC8586728.
      Citations: 2     Fields:    Translation:HumansCells
    61. Moss MH, Lugogo NL, Castro M, Hanania NA, Saralaya D, Dobek R, Vyshnyvetskyy I, Bruey JM, Osterhout R, Tompkins CA, Dittrich K, Raghupathi K, Ortega H, LEDA Investigators, Ludwig-Sengpiel A, Ojanguren I. Results of a Phase 2b Trial With GB001, a Prostaglandin D2 Receptor 2 Antagonist, in Moderate to Severe Eosinophilic Asthma. Chest. 2022 08; 162(2):297-308. PMID: 35248549.
      Citations:    Fields:    
    62. Garner O, Ramey JS, Hanania NA. Management of Life-Threatening Asthma: Severe Asthma Series. Chest. 2022 10; 162(4):747-756. PMID: 35218742.
      Citations:    Fields:    
    63. Park C, Razjouyan J, Hanania NA, Helmer DA, Naik AD, Lynch KE, Amos CI, Sharafkhaneh A. Elevated Risk of Chronic Respiratory Conditions within 60 Days of COVID-19 Hospitalization in Veterans. Healthcare (Basel). 2022 Feb 04; 10(2). PMID: 35206914; PMCID: PMC8872176.
      Citations:    
    64. Yohannes AM, Casaburi R, Dryden S, Hanania NA. Predictors of premature discontinuation and prevalence of dropouts from a pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease. Respir Med. 2022 03; 193:106742. PMID: 35091205.
      Citations: 1     Fields:    Translation:Humans
    65. Wallick C, To TM, Korom S, Masters H, Hanania NA, Moawad D. Impact of influenza infection on the short- and long-term health of patients with chronic obstructive pulmonary disease. J Med Econ. 2022 Jan-Dec; 25(1):930-939. PMID: 35837794.
      Citations:    Fields:    Translation:Humans
    66. Iyer AS, Parekh TM, O'Toole J, Bhatt SP, Eakin MN, Krishnan JA, Yohannes AM, Woodruff PG, Cooper CB, Kanner RE, Hanania NA, Dransfield MT, Regan EA, Hoth KF, Kim V, COPDGene and SPIROMICS Investigators. Clinically Significant and Comorbid Anxiety and Depression Symptoms Predict Severe Respiratory Exacerbations in Smokers: A Post Hoc Analysis of the COPDGene and SPIROMICS Cohorts. Ann Am Thorac Soc. 2022 01; 19(1):143-146. PMID: 34343034; PMCID: PMC9797036.
      Citations:    Fields:    Translation:Humans
    67. Amin AN, Cornelison S, Woods JA, Hanania NA. Managing hospitalized patients with a COPD exacerbation: the role of hospitalists and the multidisciplinary team. Postgrad Med. 2022 Mar; 134(2):152-159. PMID: 34913814.
      Citations:    Fields:    Translation:Humans
    68. Kumar P, Osahon O, Vides DB, Hanania N, Minard CG, Sekhar RV. Severe Glutathione Deficiency, Oxidative Stress and Oxidant Damage in Adults Hospitalized with COVID-19: Implications for GlyNAC (Glycine and N-Acetylcysteine) Supplementation. Antioxidants (Basel). 2021 Dec 27; 11(1). PMID: 35052554; PMCID: PMC8773164.
      Citations: 8     
    69. Pavord ID, Hanania NA, Corren J. Controversies in Allergy: Choosing a Biologic for Patients with Severe Asthma. J Allergy Clin Immunol Pract. 2022 02; 10(2):410-419. PMID: 34958982.
      Citations:    Fields:    Translation:HumansCells
    70. Rosas IO, Diaz G, Gottlieb RL, Robinson P, Hunter BD, Overcash JS, Hanania NA, Skarbnik A, Garcia-Diaz J, Gordeev I, Gordon O, Graham E, Lewin-Koh N, Tsai L, Tuckwell K, Cao H, Brainard D, Olsson JK, Lobo SM, Cavalcante AW, Carratal? J. Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial. Intensive Care Med. 2021 11; 47(11):1258-1270. PMID: 34609549; PMCID: PMC8490137.
      Citations: 17     Fields:    Translation:Humans
    71. Ari A, Blain K, Soubra S, Hanania NA. Treating COPD Patients with Inhaled Medications in the Era of COVID-19 and Beyond: Options and Rationales for Patients at Home. Int J Chron Obstruct Pulmon Dis. 2021; 16:2687-2695. PMID: 34611397; PMCID: PMC8487292.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    72. Mohan A, Ludwig A, Brehm C, Lugogo NL, Sumino K, Hanania NA. Revisiting Mild Asthma: Current Knowledge and Future Needs. Chest. 2022 01; 161(1):26-39. PMID: 34543667.
      Citations: 1     Fields:    Translation:Humans
    73. Strollo HC, Nouraie SM, Hoth KF, Riley CM, Karoleski C, Zhang Y, Hanania NA, Bowler RP, Bon J, Sciurba FC. Association of Systemic Inflammation with Depressive Symptoms in Individuals with COPD. Int J Chron Obstruct Pulmon Dis. 2021; 16:2515-2522. PMID: 34511896; PMCID: PMC8423410.
      Citations: 1     Fields:    Translation:Humans
    74. Hanania NA, Fortis S, Haselkorn T, Gupta S, Mumneh N, Yoo B, Holweg CTJ, Chipps BE. Omalizumab in Asthma with Fixed Airway Obstruction: Post Hoc Analysis of EXTRA. J Allergy Clin Immunol Pract. 2022 01; 10(1):222-228. PMID: 34419680.
      Citations: 3     Fields:    Translation:Humans
    75. Hanania NA, Caveney S, Soule T, Tombs L, Lettis S, Crim C, Mannino DM, Patel H, Boucot IH. Effect of Age on Efficacy and Safety of Fluticasone Furoate/Vilanterol (FF/VI), Umeclidinium (UMEC), and UMEC + FF/VI in Patients with Chronic Obstructive Pulmonary Disease: Analyses of Five Randomized Clinical Trials. Int J Chron Obstruct Pulmon Dis. 2021; 16:1925-1938. PMID: 34194225; PMCID: PMC8238523.
      Citations:    Fields:    Translation:Humans
    76. Ebrahimpour A, Wang M, Li L, Jegga AG, Bonnen MD, Eissa NT, Raghu G, Jyothula S, Kheradmand F, Hanania NA, Rosas IO, Ghebre YT. Esomeprazole attenuates inflammatory and fibrotic response in lung cells through the MAPK/Nrf2/HO1 pathway. J Inflamm (Lond). 2021 May 19; 18(1):17. PMID: 34011367; PMCID: PMC8136131.
      Citations: 3     
    77. Wu TD, Fawzy A, Brigham E, McCormack MC, Rosas I, Villareal DT, Hanania NA. Association of Triglyceride-Glucose Index and Lung Health: A Population-Based Study. Chest. 2021 09; 160(3):1026-1034. PMID: 33839084; PMCID: PMC8449007.
      Citations: 4     Fields:    Translation:Humans
    78. Hanania NA, Yohannes AM, Ozol-Godfrey A, Tocco M, Goodin T, Sharma S, Sanjar S. Improvement in Lung Function and Patient-Reported Outcomes in Patients with COPD with Comorbid Anxiety and Depression Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies. Int J Chron Obstruct Pulmon Dis. 2021; 16:865-875. PMID: 33833507; PMCID: PMC8020329.
      Citations: 1     Fields:    Translation:Humans
    79. Pepper AN, Hanania NA, Casale TB, Humbert M. How to Assess Effectiveness of Biologics for Asthma and What Steps to Take When There Is Not Benefit. J Allergy Clin Immunol Pract. 2021 03; 9(3):1081-1088. PMID: 33685606.
      Citations: 3     Fields:    Translation:HumansCells
    80. Assaf SM, Tarasevych SP, Diamant Z, Hanania NA. Asthma and severe acute respiratory syndrome coronavirus 2019: current evidence and knowledge gaps. Curr Opin Pulm Med. 2021 01; 27(1):45-53. PMID: 33065601.
      Citations: 6     Fields:    Translation:Humans
    81. Diamant Z, Hanania NA. Editorial: Dealing with asthma during the turbulent times of coronavirus disease-2019. Curr Opin Pulm Med. 2021 01; 27(1):1-2. PMID: 33105236.
      Citations:    Fields:    
    82. Bourdin A, Criner G, Dransfield M, Halpin DMG, Han MK, Jones CE, Kalhan R, Lange P, Lettis S, Lipson DA, Lomas DA, Martin N, Martinez FJ, Quasny H, Sail L, Siler TM, Singh D, Thomashow B, Watz H, Wise R, Hanania NA, Devouassoux G, Echave-Sustaeta Mar?a-Tom? JM. InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: Analysis of the Western Europe and North America Regions. Chronic Obstr Pulm Dis. 2021 Jan; 8(1). PMID: 33156982; PMCID: PMC8047616.
      Citations:    
    83. Kao CC, Hanania NA, Parulekar AD. The impact of fungal allergic sensitization on asthma. Curr Opin Pulm Med. 2021 01; 27(1):3-8. PMID: 33027187.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    84. Heffler E, Nenasheva N, Menzies-Gow A, Moreira-Jorge A, Nissen F, Hanania NA, Quirce S, Demoly P. Revisiting Late-Onset Asthma: Clinical Characteristics and Association with Allergy. J Asthma Allergy. 2020; 13:743-752. PMID: 33408487; PMCID: PMC7781019.
      Citations: 1     
    85. Tervonen T, Martinez FJ, Hanania NA, Heidenreich S, Eudicone JM, Gilbert I. Dual-combination maintenance inhaler preferences in asthma and chronic obstructive pulmonary disease: A patient-centered benefit-risk assessment. Respir Med. 2021 01; 176:106278. PMID: 33387985.
      Citations: 1     Fields:    
    86. Yohannes AM, N Eakin M, Holbrook JT, Sugar EA, Henderson R, Baker AM, Casper AS, Kaminsky DA, Rea AL, Mathews AM, Que LG, Ramsdell JW, Gerald LB, Wise RA, Hanania NA. Association of mild cognitive impairment and characteristic of COPD and overall health status in a cohort study. Expert Rev Respir Med. 2021 01; 15(1):153-159. PMID: 33054443.
      Citations: 1     Fields:    Translation:Humans
    87. Yohannes AM, Dryden S, Casaburi R, Hanania NA. Long-Term Benefits of Pulmonary Rehabilitation in Patients With COPD: A 2-Year Follow-Up Study. Chest. 2021 03; 159(3):967-974. PMID: 33098829.
      Citations: 3     Fields:    Translation:Humans
    88. Hanania NA, Mannino DM, Criner GJ, Dransfield MT, Han MK, Jones CE, Kilbride S, Lomas DA, Martin N, Martinez FJ, Singh D, Wise RA, Halpin DMG, Lima R, Lipson DA. Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD: A Post Hoc Analysis of the Informing the Pathway of COPD Treatment Trial. Chest. 2021 03; 159(3):985-995. PMID: 33031829.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    89. Strand M, Austin E, Moll M, Pratte KA, Regan EA, Hayden LP, Bhatt SP, Boriek AM, Casaburi R, Silverman EK, Fortis S, Ruczinski I, Koegler H, Rossiter HB, Occhipinti M, Hanania NA, Gebrekristos HT, Lynch DA, Kunisaki KM, Young KA, Sieren JC, Ragland M, Hokanson JE, Lutz SM, Make BJ, Kinney GL, Cho MH, Pistolesi M, DeMeo DL, Sciurba FC, Comellas AP, Diaz AA, Barjaktarevic I, Bowler RP, Kanner RE, Dransfield MT, Crapo JD, Peters SP, Ortega VE. A Risk Prediction Model for Mortality Among Smokers in the COPDGene? Study. Chronic Obstr Pulm Dis. 2020 Oct; 7(4):346-361. PMID: 32877963; PMCID: PMC7883903.
      Citations: 6     
    90. Lee LA, Bailes Z, Barnes N, Boulet LP, Edwards D, Fowler A, Hanania NA, Kerstjens HAM, Kerwin E, Nathan R, Oppenheimer J, Papi A, Pascoe S, Brusselle G, Peachey G, Sule N, Tabberer M, Pavord ID. Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial. Lancet Respir Med. 2021 01; 9(1):69-84. PMID: 32918892.
      Citations: 22     Fields:    Translation:HumansCTClinical Trials
    91. Agache I, Akdis CA, Akdis M, Canonica GW, Casale T, Chivato T, Corren J, Chu DK, Del Giacco S, Eiwegger T, Flood B, Firinu D, Gern JE, Hamelmann E, Hanania N, Knibb R, Nair P, O'Mahony L, Papadopoulos NG, Papi A, Park HS, Shamji M, Schwarze J, Palomares O, Jutel M, Hern?ndez-Mart?n I, M?kel? M, P?rez de Llano L, Pfaar O, Quirce S, Sastre J. EAACI Biologicals Guidelines-Recommendations for severe asthma. Allergy. 2021 01; 76(1):14-44. PMID: 32484954.
      Citations: 18     Fields:    Translation:Humans
    92. Bose S, Bime C, Henderson RJ, Blake KV, Castro M, DiMango E, Hanania NA, Holbrook JT, Irvin CG, Kraft M, Peters SP, Reibman J, Sugar EA, Sumino K, Wise RA, Rogers L, American Lung Association Airways Clinical Research Centers. Biomarkers of Type 2 Airway Inflammation as Predictors of Loss of Asthma Control During Step-Down Therapy for Well-Controlled Disease: The Long-Acting Beta-Agonist Step-Down Study (LASST). J Allergy Clin Immunol Pract. 2020 Nov - Dec; 8(10):3474-3481. PMID: 32693214; PMCID: PMC8026280.
      Citations: 1     Fields:    Translation:Humans
    93. Tervonen T, Hawken N, Hanania NA, Martinez FJ, Heidenreich S, Gilbert I. Maintenance inhaler therapy preferences of patients with asthma or chronic obstructive pulmonary disease: a discrete choice experiment. Thorax. 2020 09; 75(9):735-743. PMID: 32631932; PMCID: PMC7476258.
      Citations: 7     Fields:    Translation:Humans
    94. Shaddox E, Peterson CB, Stingo FC, Hanania NA, Cruickshank-Quinn C, Kechris K, Bowler R, Vannucci M. Bayesian inference of networks across multiple sample groups and data types. Biostatistics. 2020 07 01; 21(3):561-576. PMID: 30590505; PMCID: PMC7672535.
      Citations: 2     Fields:    Translation:Humans
    95. Busse WW, Lu Y, Corren J, Hanania NA, Chipps BE, Katelaris CH, FitzGerald JM, Quirce S, Ford LB, Rice MS, Kamat S, Khan AH, Jagerschmidt A, Harel S, Rowe P, Pirozzi G, Amin N, Ruddy M, Graham NMH, Teper A, Maspero JF. Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2020 11; 125(5):565-576.e1. PMID: 32474156.
      Citations: 6     Fields:    Translation:HumansCellsCTClinical Trials
    96. Aguiar R, Martin B, Ansotegui IJ, Ebisawa M, Caminati M, Canonica GW, Carr T, Chupp G, Corren J, Park HS, Hanania NA, Rosenwasser L, Bernstein JA, Caraballo L, Chang YS, Chikhladze M, Levin M, Passalacqua G, Peden DB, Rouadi PW, Sublett JL, Wong GWK, Bleecker ER, Morais-Almeida M, Arruda LK, D?vila I, S?nchez-Borges M, Virchow JC, Y??ez A, Fiocchi A, Gonz?lez-Diaz SN, Tanno LK, Ortega-Martell JA. COVID-19, asthma, and biological therapies: What we need to know. World Allergy Organ J. 2020 May; 13(5):100126. PMID: 32426090; PMCID: PMC7229954.
      Citations: 40     
    97. Papadopoulos NG, Holgate ST, Hanania NA, Halpin DMG, Chapman KR, Gavornikova M, Price DB, Kaplan A, Heaney LG, Humbert M, Bourdin A. Reducing the hidden burden of severe asthma: recognition and referrals from primary practice. J Asthma. 2021 07; 58(7):849-854. PMID: 32347748.
      Citations: 3     Fields:    Translation:Humans
    98. Agache I, Rocha C, Beltran J, Song Y, Posso M, Alonso-Coello P, Akdis C, Akdis M, Canonica GW, Casale T, Chivato T, Corren J, Del Giacco S, Eiwegger T, Firinu D, Gern JE, Hanania N, Nair P, O'Mahony L, Papadopoulos NG, Papi A, Park HS, Shamji M, Schwarze J, Canelo-Aybar C, Palomares O, Jutel M, Sol? I, Hamelmann E, M?kel? M, Mart?n IH, P?rez de Llano L, Quirce S, Sastre J. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma. Allergy. 2020 05; 75(5):1043-1057. PMID: 32064642.
      Citations: 18     Fields:    Translation:Humans
    99. Hanania NA, Papi A, Anzueto A, Martinez FJ, Rossman KA, Cappelletti CS, Duncan EA, Nyberg JS, Dorinsky PM. Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD. ERJ Open Res. 2020 Apr; 6(2). PMID: 32363206; PMCID: PMC7184113.
      Citations: 1     
    100. Buhl R, Korn S, Menzies-Gow A, Chapman KR, Canonica GW, Donica M, Kuhlbusch K, Korom S, Hanania NA, Aubier M, Picado C. Prospective, Single-Arm, Longitudinal Study of Biomarkers in Real-World Patients with Severe Asthma. J Allergy Clin Immunol Pract. 2020 09; 8(8):2630-2639.e6. PMID: 32304841.
      Citations: 7     Fields:    Translation:HumansCells
    101. Bachert C, Hanania NA, Zhang N, Holgate S, Buhl R, Humbert M, Br?ker BM. Staphylococcus aureus and its IgE-inducing enterotoxins in asthma: current knowledge. Eur Respir J. 2020 04; 55(4). PMID: 31980492.
      Citations: 16     Fields:    Translation:HumansCells
    102. Myers LC, Faridi MK, Hasegawa K, Hanania NA, Camargo CA. The Hospital Readmissions Reduction Program and Readmissions for Chronic Obstructive Pulmonary Disease, 2006-2015. Ann Am Thorac Soc. 2020 04; 17(4):450-456. PMID: 31860333; PMCID: PMC7175978.
      Citations: 13     Fields:    Translation:Humans
    103. Agache I, Song Y, Rocha C, Beltran J, Posso M, Steiner C, Alonso-Coello P, Akdis C, Akdis M, Canonica GW, Casale T, Chivato T, Corren J, Del Giacco S, Eiwegger T, Firinu D, Gern JE, Hanania N, Nair P, O'Mahony L, Papadopoulos NG, Papi A, Park HS, Shamji M, Schwarze J, Canelo-Aybar C, Palomares O, Jutel M, Hamelmann E, M?kel? M, Mart?n IH, P?rez de Llano L, Quirce S, Sastre J. Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma. Allergy. 2020 05; 75(5):1058-1068. PMID: 32154939.
      Citations: 20     Fields:    Translation:Humans
    104. Walther CP, Nambi V, Hanania NA, Navaneethan SD. Diagnosis and Management of Pulmonary Hypertension in Patients With CKD. Am J Kidney Dis. 2020 06; 75(6):935-945. PMID: 32199709; PMCID: PMC7247937.
      Citations: 6     Fields:    Translation:Humans
    105. Bruhl RJ, Perkison WB, Hanania NA, McNeill LH, Oluyomi AO, Fiesinger EB, Minard CG, Solomon A, Hamilton WJ, Patient/Stakeholder Advisory Board and other members of the HIITBAC Research Team:, Butler B, Caldwell J, Crosby E, Davis C, Galvan H, Harris R, Lacour-Chestnut F, Martin C, Pannell S, Phipps K, Richardson G, Solomon A, White W, Boles J, Rangel A, Virk R, Brock M, Guffey D, Ramamurthy U, Persse D, Maffei S, Chan W, Reyes B. Design of a home-based intervention for Houston-area African-American adults with asthma: Methods and lessons learned from a pragmatic randomized trial. Contemp Clin Trials. 2020 04; 91:105977. PMID: 32151753.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    106. Agache I, Beltran J, Akdis C, Akdis M, Canelo-Aybar C, Canonica GW, Casale T, Chivato T, Corren J, Del Giacco S, Eiwegger T, Firinu D, Gern JE, Hanania N, Nair P, O'Mahony L, Papadopoulos NG, Papi A, Park HS, Posso M, Rocha C, Shamji M, Song Y, Steiner C, Schwarze J, Alonso-Coello P, Palomares O, Jutel M, Hamelmann E, M?kel? M, Hern?ndez-Mart?n I, P?rez de Llano L, Quirce S, Sastre J. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma. Allergy. 2020 05; 75(5):1023-1042. PMID: 32034960.
      Citations: 45     Fields:    Translation:Humans
    107. Hanania NA, Djukanovic R, Heaney LG, Yang M, Yoo B, Iqbal A, Griffin NM, Chipps BE. Determinants of lung function improvement with omalizumab in adults with allergic asthma. J Allergy Clin Immunol Pract. 2020 06; 8(6):2068-2070. PMID: 31981731.
      Citations: 1     Fields:    Translation:Humans
    108. Vijverberg S, Hanania NA, Diamant Z, Ulrik CS. Precision medicine and treatable traits in chronic airway diseases - where do we stand? Curr Opin Pulm Med. 2020 01; 26(1):33-39. PMID: 31644440.
      Citations: 5     Fields:    Translation:Humans
    109. Diamant Z, van den Berge M, Hanania NA. Editorial: Asthma: a modifiable disease on a crossroad. Curr Opin Pulm Med. 2020 01; 26(1):1-2. PMID: 31724963.
      Citations:    Fields:    
    110. Rogliani P, Calzetta L, Matera MG, Laitano R, Ritondo BL, Hanania NA, Cazzola M. Severe Asthma and Biological Therapy: When, Which, and for Whom. Pulm Ther. 2020 Jun; 6(1):47-66. PMID: 32048241; PMCID: PMC7229123.
      Citations: 18     
    111. Hanania AN, Hanania NA. Response. Chest. 2019 12; 156(6):1276. PMID: 31812201.
      Citations:    Fields:    Translation:HumansCells
    112. Narendra D, Blixt J, Hanania NA. Immunological biomarkers in severe asthma. Semin Immunol. 2019 12; 46:101332. PMID: 31735516.
      Citations: 9     Fields:    Translation:HumansCells
    113. Lowe KE, Regan EA, Anzueto A, Austin E, Austin JHM, Beaty TH, Benos PV, Benway CJ, Bhatt SP, Bleecker ER, Bodduluri S, Bon J, Boriek AM, Boueiz AR, Bowler RP, Budoff M, Casaburi R, Castaldi PJ, Charbonnier JP, Cho MH, Comellas A, Conrad D, Costa Davis C, Criner GJ, Curran-Everett D, Curtis JL, DeMeo DL, Diaz AA, Dransfield MT, Dy JG, Fawzy A, Fleming M, Flenaugh EL, Foreman MG, Fortis S, Gebrekristos H, Grant S, Gu T, Gupta A, Han MK, Hanania NA, Hansel NN, Hayden LP, Hersh CP, Hobbs BD, Hoffman EA, Hogg JC, Hokanson JE, Hoth KF, Hsiao A, Humphries S, Jacobs K, Jacobson FL, Kazerooni EA, Kim V, Kim WJ, Kinney GL, Koegler H, Lutz SM, Lynch DA, MacIntye NR, Make BJ, Marchetti N, Martinez FJ, Maselli DJ, Mathews AM, McCormack MC, McDonald MN, McEvoy CE, Moll M, Molye SS, Murray S, Nath H, Newell JD, Occhipinti M, Paoletti M, Parekh T, Pistolesi M, Pratte KA, Putcha N, Ragland M, Reinhardt JM, Rennard SI, Rosiello RA, Ross JC, Rossiter HB, Ruczinski I, San Jose Estepar R, Sciurba FC, Sieren JC, Singh H, Soler X, Steiner RM, Strand MJ, Stringer WW, Tal-Singer R, Thomashow B, Wan ES, Washko GR, Michael Wells J, Wendt CH, Westney G, Wilson A, Wise RA, Yen A, Young K, Yun J, Silverman EK, Crapo JD, Grenier PA, Vegas S?nchez-Ferrero G, Walsh JW. COPDGene? 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease. Chronic Obstr Pulm Dis. 2019 Nov; 6(5):384-399. PMID: 31710793; PMCID: PMC7020846.
      Citations: 53     
    114. Yohannes AM, Dryden S, Hanania NA. The responsiveness of the Manchester Chronic Obstructive Pulmonary Disease Fatigue Scale to pulmonary rehabilitation. Ther Adv Chronic Dis. 2019; 10:2040622319882206. PMID: 31695862; PMCID: PMC6820178.
      Citations: 1     
    115. Corren J, Castro M, O'Riordan T, Hanania NA, Pavord ID, Quirce S, Chipps BE, Wenzel SE, Thangavelu K, Rice MS, Harel S, Jagerschmidt A, Khan AH, Kamat S, Maroni J, Rowe P, Lu Y, Amin N, Pirozzi G, Ruddy M, Graham NMH, Teper A. Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma. J Allergy Clin Immunol Pract. 2020 02; 8(2):516-526. PMID: 31521831.
      Citations: 39     Fields:    Translation:Humans
    116. Assaf SM, Hanania NA. Biological treatments for severe asthma. Curr Opin Allergy Clin Immunol. 2019 08; 19(4):379-386. PMID: 31169594.
      Citations: 5     Fields:    Translation:HumansAnimals
    117. Maselli DJ, Hanania NA. Management of asthma COPD overlap. Ann Allergy Asthma Immunol. 2019 10; 123(4):335-344. PMID: 31376487.
      Citations: 8     Fields:    Translation:Humans
    118. Li P, Kavati A, Puckett JT, Jahnke J, Busse P, Hanania NA, Ortiz B, Doshi JA. Omalizumab Treatment Patterns Among Patients with Asthma in the US Medicare Population. J Allergy Clin Immunol Pract. 2020 02; 8(2):507-515.e10. PMID: 31336178.
      Citations: 4     Fields:    Translation:Humans
    119. Rogliani P, Matera MG, Calzetta L, Hanania NA, Page C, Rossi I, Andreadi A, Galli A, Coppola A, Cazzola M, Lauro D. Long-term observational study on the impact of GLP-1R agonists on lung function in diabetic patients. Respir Med. 2019 Jul - Aug; 154:86-92. PMID: 31228775.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    120. Maselli DJ, Bhatt SP, Anzueto A, Bowler RP, DeMeo DL, Diaz AA, Dransfield MT, Fawzy A, Foreman MG, Hanania NA, Hersh CP, Kim V, Kinney GL, Putcha N, Wan ES, Wells JM, Westney GE, Young KA, Silverman EK, Han MK, Make BJ. Clinical Epidemiology of COPD: Insights From 10 Years of the COPDGene Study. Chest. 2019 08; 156(2):228-238. PMID: 31154041; PMCID: PMC7198872.
      Citations: 22     Fields:    Translation:Humans
    121. Hanania NA, O'Donnell DE. Activity-related dyspnea in chronic obstructive pulmonary disease: physical and psychological consequences, unmet needs, and future directions. Int J Chron Obstruct Pulmon Dis. 2019; 14:1127-1138. PMID: 31213793; PMCID: PMC6538882.
      Citations: 26     Fields:    Translation:HumansAnimals
    122. Narendra DK, Hanania NA. Targeting IL-5 in COPD. Int J Chron Obstruct Pulmon Dis. 2019; 14:1045-1051. PMID: 31190789; PMCID: PMC6529620.
      Citations: 11     Fields:    Translation:AnimalsCells
    123. Brooks EA, Massanari M, Hanania NA, Weiner DJ. Cost-effectiveness of fractional exhaled nitric oxide (FeNO) measurement in predicting response to omalizumab in asthma. Clinicoecon Outcomes Res. 2019; 11:301-307. PMID: 31114270; PMCID: PMC6497051.
      Citations: 4     
    124. Hanania AN, Mainwaring W, Ghebre YT, Hanania NA, Ludwig M. Radiation-Induced Lung Injury: Assessment and Management. Chest. 2019 07; 156(1):150-162. PMID: 30998908; PMCID: PMC8097634.
      Citations: 105     Fields:    Translation:HumansPHPublic Health
    125. Pavord ID, Hanania NA. Controversies in Allergy: Should Severe Asthma with Eosinophilic Phenotype Always Be Treated with Anti-IL-5 Therapies. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1430-1436. PMID: 30962155.
      Citations: 1     Fields:    Translation:Humans
    126. Iyer AS, Holm KE, Bhatt SP, Kim V, Kinney GL, Wamboldt FS, Jacobs MR, Regan EA, Armstrong HF, Lowe KE, Martinez CH, Dransfield MT, Foreman MG, Shinozaki G, Hanania NA, Wise RA, Make BJ, Hoth KF, COPDGene Investigators. Symptoms of anxiety and depression and use of anxiolytic-hypnotics and antidepressants in current and former smokers with and without COPD - A cross sectional analysis of the COPDGene cohort. J Psychosom Res. 2019 03; 118:18-26. PMID: 30782350; PMCID: PMC6383809.
      Citations: 8     Fields:    Translation:Humans
    127. Diamant Z, Aalders W, Parulekar A, Bjermer L, Hanania NA. Targeting lipid mediators in asthma: time for reappraisal. Curr Opin Pulm Med. 2019 01; 25(1):121-127. PMID: 30422894.
      Citations: 6     Fields:    Translation:Humans
    128. Hanania NA, Boulet LP. The many faces of asthma-chronic obstructive pulmonary disease overlap. Curr Opin Pulm Med. 2019 01; 25(1):1-10. PMID: 30461532.
      Citations: 3     Fields:    Translation:Humans
    129. Hanania NA, Sethi S, Koltun A, Ward JK, Spanton J, Ng D. Long-term safety and efficacy of formoterol fumarate inhalation solution in patients with moderate-to-severe COPD. Int J Chron Obstruct Pulmon Dis. 2019; 14:117-127. PMID: 30643398; PMCID: PMC6311322.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    130. Yohannes AM, Dryden S, Hanania NA. Validity and Responsiveness of the?Depression Anxiety Stress Scales-21?(DASS-21) in?COPD. Chest. 2019 06; 155(6):1166-1177. PMID: 30594559.
      Citations: 15     Fields:    Translation:Humans
    131. Hanania NA, Chipps BE, Griffin NM, Yoo B, Iqbal A, Casale TB. Omalizumab effectiveness in asthma-COPD overlap: Post hoc analysis of PROSPERO. J Allergy Clin Immunol. 2019 04; 143(4):1629-1633.e2. PMID: 30576755.
      Citations: 10     Fields:    Translation:Humans
    132. Skolnik N, Kaplan AG, Lake T, Hayden ML, Hanania NA. COPD Management in the Primary Care Setting. J Fam Pract. 2018 10; 67(10 Suppl):S27-S32. PMID: 30423008.
      Citations:    Fields:    Translation:Humans
    133. Han MK, Hanania NA, Martinez FJ. Confronting the Challenge of COPD: What Is New in the Approaches to Diagnosis, Treatment, and Patient Outcomes. Chest. 2018 10; 154(4):984-985. PMID: 30290933.
      Citations: 3     Fields:    
    134. Calzetta L, Hanania NA, Dini FL, Goldstein MF, Fairweather WR, Howard WW, Cazzola M. Impact of doxofylline compared to theophylline in asthma: A pooled analysis of functional and clinical outcomes from two multicentre, double-blind, randomized studies (DOROTHEO 1 and DOROTHEO 2). Pulm Pharmacol Ther. 2018 12; 53:20-26. PMID: 30219705.
      Citations: 3     Fields:    Translation:Humans
    135. D'Urzo AD, Cazzola M, Hanania NA, Buhl R, Maleki-Yazdi MR. New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology. Int J Chron Obstruct Pulmon Dis. 2018; 13:2805-2819. PMID: 30233171; PMCID: PMC6135066.
      Citations: 1     Fields:    Translation:Humans
    136. Maselli DJ, Hanania NA. Asthma COPD overlap: Impact of associated comorbidities. Pulm Pharmacol Ther. 2018 10; 52:27-31. PMID: 30172866.
      Citations: 5     Fields:    Translation:Humans
    137. Maselli DJ, Hardin M, Christenson SA, Hanania NA, Hersh CP, Adams SG, Anzueto A, Peters JI, Han MK, Martinez FJ. Clinical Approach to the Therapy of Asthma-COPD Overlap. Chest. 2019 01; 155(1):168-177. PMID: 30077690; PMCID: PMC6688980.
      Citations: 14     Fields:    Translation:Humans
    138. Baker AM, Holbrook JT, Yohannes AM, Eakin MN, Sugar EA, Henderson RJ, Casper AS, Kaminsky DA, Rea AL, Mathews AM, Que LG, Ramsdell JW, Gerald LB, Wise RA, Hanania NA, American Lung Association Airways Clinical Research Centers. Test Performance Characteristics of the AIR, GAD-7, and HADS-Anxiety Screening Questionnaires for Anxiety in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2018 Aug; 15(8):926-934. PMID: 29986152; PMCID: PMC7212591.
      Citations: 12     Fields:    
    139. Braddock M, Hanania NA, Sharafkhaneh A, Colice G, Carlsson M. Potential Risks Related to Modulating Interleukin-13 and Interleukin-4 Signalling: A Systematic Review. Drug Saf. 2018 05; 41(5):489-509. PMID: 29411337; PMCID: PMC5938313.
      Citations: 15     Fields:    Translation:HumansAnimalsCells
    140. Braman SS, Carlin BW, Hanania NA, Mahler DA, Ohar JA, Pinto-Plata V, Shah T, Eubanks D, Dhand R. Results of a Pulmonologist Survey Regarding Knowledge and Practices With Inhalation Devices for COPD. Respir Care. 2018 07; 63(7):840-848. PMID: 29717099.
      Citations: 5     Fields:    Translation:Humans
    141. Hanania NA, Massanari M, Jain N. Measurement of fractional exhaled nitric oxide in real-world clinical practice alters asthma treatment decisions. Ann Allergy Asthma Immunol. 2018 04; 120(4):414-418.e1. PMID: 29408317.
      Citations: 3     Fields:    Translation:Humans
    142. Hanania NA, Braman S, Adams SG, Adewuya R, Ari A, Brooks J, Mahler DA, Ohar JA, Peters J, Sanjar S. The Role of Inhalation Delivery Devices in COPD: Perspectives of Patients and Health Care Providers. Chronic Obstr Pulm Dis. 2018 Apr 01; 5(2):111-123. PMID: 30374449; PMCID: PMC6190525.
      Citations: 15     
    143. Dhand R, Mahler DA, Carlin BW, Hanania NA, Ohar JA, Pinto-Plata V, Shah T, Eubanks D, Braman SS. Results of a Patient Survey Regarding COPD Knowledge, Treatment Experiences, and Practices With Inhalation Devices. Respir Care. 2018 07; 63(7):833-839. PMID: 29559537.
      Citations: 11     Fields:    Translation:Humans
    144. Cazzola M, Calzetta L, Matera MG, Hanania NA, Rogliani P. How does race/ethnicity influence pharmacological response to asthma therapies? Expert Opin Drug Metab Toxicol. 2018 Apr; 14(4):435-446. PMID: 29528249.
      Citations: 4     Fields:    Translation:Humans
    145. Donohue JF, Bollu VK, Stull DE, Nelson LM, Williams VS, Stensland MD, Hanania NA. Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial. Int J Chron Obstruct Pulmon Dis. 2018; 13:499-508. PMID: 29440887; PMCID: PMC5804733.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    146. Yohannes AM, Kaplan A, Hanania NA. Anxiety and Depression in Chronic Obstructive Pulmonary Disease: Recognition and Management. Cleve Clin J Med. 2018 Feb; 85(2 Suppl 1):S11-S18. PMID: 29494328.
      Citations: 14     Fields:    Translation:Humans
    147. Yohannes AM, Kaplan A, Hanania NA. COPD in Primary Care: Key Considerations for Optimized Management: Anxiety and Depression in Chronic Obstructive Pulmonary Disease: Recognition and Management. J Fam Pract. 2018 02; 67(2 Suppl):S11-S18. PMID: 29443332.
      Citations: 7     Fields:    Translation:Humans
    148. Busse W, Hanania NA, Humbert M. Controversies and opportunities in severe asthma. Curr Opin Pulm Med. 2018 01; 24(1):83-93. PMID: 29059087.
      Citations: 5     Fields:    Translation:Humans
    149. Hanania NA, Diamant Z. The road to precision medicine in asthma: challenges and opportunities. Curr Opin Pulm Med. 2018 01; 24(1):1-3. PMID: 29045293.
      Citations: 1     Fields:    
    150. Parulekar AD, Kao CC, Hanania NA, Diamant Z. Targeting the interleukin-4 and interleukin-13 pathways in severe asthma: current knowledge and future needs. Curr Opin Pulm Med. 2018 01; 24(1):50-55. PMID: 29036019.
      Citations: 17     Fields:    Translation:HumansCells
    151. Bousquet J, Brusselle G, Buhl R, Busse WW, Cruz AA, Djukanovic R, Hanania NA, Menzies Gow A, Phipatanakul W, Wechsler ME, Domingo C, Humbert M, Wahn U. Care pathways for the selection of a biologic in severe asthma. Eur Respir J. 2017 12; 50(6). PMID: 29217605.
      Citations: 21     Fields:    Translation:Humans
    152. Narendra DK, Hanania NA. Procalcitonin in Chronic Obstructive Pulmonary Disease Exacerbations: Is It Ready for Primetime Use? Ann Am Thorac Soc. 2017 12; 14(12):1757-1758. PMID: 29192825.
      Citations:    Fields:    Translation:Humans
    153. Parulekar AD, Martinez C, Tsai CL, Locantore N, Atik M, Yohannes AM, Kao CC, Al-Azzawi H, Mohsin A, Wise RA, Foreman MG, Demeo DL, Regan EA, Make BJ, Boriek AM, Wiener LE, Hanania NA. Examining the Effects of Age on Health Outcomes of Chronic Obstructive Pulmonary Disease: Results From the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease Study and Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate Endpoints Cohorts. J Am Med Dir Assoc. 2017 Dec 01; 18(12):1063-1068. PMID: 29169736; PMCID: PMC5955393.
      Citations: 3     Fields:    Translation:Humans
    154. Rogers L, Sugar EA, Blake K, Castro M, Dimango E, Hanania NA, Happel KI, Peters SP, Reibman J, Saams J, Teague WG, Wise RA, Holbrook JT, American Lung Association Airways Clinical Research Centers. Step-Down Therapy for Asthma Well Controlled on Inhaled Corticosteroid and Long-Acting Beta-Agonist: A Randomized Clinical Trial. J Allergy Clin Immunol Pract. 2018 Mar - Apr; 6(2):633-643.e1. PMID: 28974349.
      Citations: 4     Fields:    Translation:Humans
    155. Casale TB, Chipps BE, Trzaskoma B, Haselkorn T, Omachi TA, Greenberg S, Ros?n K, Hanania NA. Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma. Allergy. 2018 02; 73(2):490-497. PMID: 28859263; PMCID: PMC5813202.
      Citations: 32     Fields:    Translation:HumansCTClinical Trials
    156. Medrek SK, Parulekar AD, Hanania NA. Predictive Biomarkers for Asthma Therapy. Curr Allergy Asthma Rep. 2017 Sep 19; 17(10):69. PMID: 28929293.
      Citations: 23     Fields:    Translation:Humans
    157. Boriek AM, Lopez MA, Velasco C, Bakir AA, Frolov A, Wynd S, Babb TG, Hanania NA, Hoffman EA, Sharafkhaneh A. Obesity modulates diaphragm curvature in subjects with and without COPD. Am J Physiol Regul Integr Comp Physiol. 2017 Nov 01; 313(5):R620-R629. PMID: 28903915; PMCID: PMC5792148.
      Citations: 6     Fields:    Translation:Humans
    158. Mangold R, Salzman GA, Williams KB, Hanania NA. Factors associated with depressive symptoms in uncontrolled asthmatics. J Asthma. 2018 05; 55(5):555-560. PMID: 28759275; PMCID: PMC6063984.
      Citations: 1     Fields:    Translation:Humans
    159. Monaco TJ, Hanania NA. Emerging inhaled long-acting beta-2 adrenoceptor agonists for the treatment of COPD. Expert Opin Emerg Drugs. 2017 09; 22(3):285-299. PMID: 28868931.
      Citations: 2     Fields:    Translation:Humans
    160. Cazzola M, Rogliani P, Calzetta L, Hanania NA, Matera MG. Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis. COPD. 2017 Oct; 14(5):552-563. PMID: 28753070.
      Citations: 15     Fields:    Translation:Humans
    161. Goto T, Faridi MK, Gibo K, Toh S, Hanania NA, Camargo CA, Hasegawa K. Trends in 30-day readmission rates after COPD hospitalization, 2006-2012. Respir Med. 2017 Sep; 130:92-97. PMID: 29206640; PMCID: PMC5718159.
      Citations: 20     Fields:    Translation:Humans
    162. Yohannes AM, Lavoie K, Vestbo J, Rennard SI, Wouters E, Hanania NA, M?lerov? H. The Association of Depressive Symptoms With Rates of Acute Exacerbations in Patients With COPD: Results From a 3-year Longitudinal Follow-up of the ECLIPSE Cohort. J Am Med Dir Assoc. 2017 Nov 01; 18(11):955-959.e6. PMID: 28733182.
      Citations: 6     Fields:    Translation:Humans
    163. Kaminsky DA, Guntupalli KK, Lippmann J, Burns SM, Brock MA, Skelly J, DeSarno M, Pecott-Grimm H, Mohsin A, LaRock-McMahon C, Warren P, Whitney MC, Hanania NA. Effect of Yoga Breathing (Pranayama) on Exercise Tolerance in Patients with Chronic Obstructive Pulmonary Disease: A Randomized, Controlled Trial. J Altern Complement Med. 2017 Sep; 23(9):696-704. PMID: 28714735; PMCID: PMC5610410.
      Citations: 11     Fields:    Translation:Humans
    164. Sapir T, Moreo KF, Greene LS, Simone LC, Carter JD, Mateka JJL, Hanania NA. Assessing Patient and Provider Perceptions of Factors Associated with Patient Engagement in Asthma Care. Ann Am Thorac Soc. 2017 May; 14(5):659-666. PMID: 28128966.
      Citations: 4     Fields:    Translation:Humans
    165. Hanania NA, Lareau SC, Yawn BP. Safety of inhaled long-acting anti-muscarinic agents in COPD. Postgrad Med. 2017 Jun; 129(5):500-512. PMID: 28395575.
      Citations: 2     Fields:    Translation:Humans
    166. Sethi S, Fogarty C, Hanania NA, Martinez FJ, Rennard S, Fries M, Orevillo C, Darken P, St Rose E, Strom S, Fischer T, Golden M, Dwivedi S, Reisner C. Erratum: Erratum: Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension? Delivery Technology Versus Foradil? Aerolizer? in Moderate-To-Severe COPD: A Randomized, Dose-Ranging Study. Chronic Obstr Pulm Dis. 2017 Apr 15; 4(3):258. PMID: 28853450; PMCID: PMC5556917.
      Citations:    
    167. Hanania NA, Tashkin DP, Kerwin EM, Donohue JF, Denenberg M, O'Donnell DE, Quinn D, Siddiqui S, Orevillo C, Maes A, Reisner C. Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension? Delivery Technology in patients with chronic obstructive pulmonary disease. Respir Med. 2017 05; 126:105-115. PMID: 28427541.
      Citations: 29     Fields:    Translation:HumansCTClinical Trials
    168. Biswas R, Hanania NA, Sabharwal A. Factors Determining In Vitro Lung Deposition of Albuterol Aerosol Delivered by Ventolin Metered-Dose Inhaler. J Aerosol Med Pulm Drug Deliv. 2017 Aug; 30(4):256-266. PMID: 28157430; PMCID: PMC5564031.
      Citations: 3     Fields:    Translation:Humans
    169. Dransfield MT, Kunisaki KM, Strand MJ, Anzueto A, Bhatt SP, Bowler RP, Criner GJ, Curtis JL, Hanania NA, Nath H, Putcha N, Roark SE, Wan ES, Washko GR, Wells JM, Wendt CH, Make BJ, COPDGene Investigators. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2017 02 01; 195(3):324-330. PMID: 27556408; PMCID: PMC5328181.
      Citations: 89     Fields:    Translation:HumansCTClinical Trials
    170. Robinson D, Buhl R, Cruz AA, Inoue H, Korom S, Nair P, Humbert M, Hanania NA. Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications. Clin Exp Allergy. 2017 Feb; 47(2):161-175. PMID: 28036144.
      Citations: 104     Fields:    Translation:HumansAnimalsCells
    171. Hanania NA, Diamant Z. Generic medications in precision medicine in asthma. Curr Opin Pulm Med. 2017 01; 23(1):1-2. PMID: 27902500.
      Citations:    Fields:    
    172. Diamant Z, Hanania NA, Parulekar AD. Role of biologics targeting type 2 airway inflammation in asthma: what have we learned so far? Curr Opin Pulm Med. 2017 01; 23(1):3-11. PMID: 27820746.
      Citations: 8     Fields:    Translation:Humans
    173. Medrek SK, Kao CC, Yang DH, Hanania NA, Parulekar AD. Fungal Sensitization Is Associated with Increased Risk of Life-Threatening Asthma. J Allergy Clin Immunol Pract. 2017 Jul - Aug; 5(4):1025-1031.e2. PMID: 28017627.
      Citations: 16     Fields:    Translation:HumansAnimals
    174. Sethi S, Fogarty C, Hanania NA, Martinez FJ, Rennard S, Fries M, Orevillo C, Darken P, St Rose E, Strom S, Fischer T, Golden M, Dwivedi S, Reisner C. Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension? Delivery Technology Versus Foradil? Aerolizer? in Moderate-To-Severe COPD: A Randomized, Dose-Ranging Study. Chronic Obstr Pulm Dis. 2016 Nov 17; 4(1):21-33. PMID: 28848908; PMCID: PMC5560247.
      Citations: 4     
    175. Wise RA, Acevedo RA, Anzueto AR, Hanania NA, Martinez FJ, Ohar JA, Tashkin DP. Guiding Principles for the Use of Nebulized Long-Acting Beta2-Agonists in Patients with COPD: An Expert Panel Consensus. Chronic Obstr Pulm Dis. 2016 Nov 15; 4(1):7-20. PMID: 28848907; PMCID: PMC5560246.
      Citations: 3     
    176. Skloot GS, Busse PJ, Braman SS, Kovacs EJ, Dixon AE, Vaz Fragoso CA, Scichilone N, Prakash YS, Pabelick CM, Mathur SK, Hanania NA, Moore WC, Gibson PG, Zieman S, Ragless BB, ATS ad hoc Committee on Asthma in the Elderly. An Official American Thoracic Society Workshop Report: Evaluation and Management of Asthma in the Elderly. Ann Am Thorac Soc. 2016 11; 13(11):2064-2077. PMID: 27831798; PMCID: PMC5466180.
      Citations: 21     Fields:    Translation:Humans
    177. Hanania NA, Korenblat P, Chapman KR, Bateman ED, Kopecky P, Paggiaro P, Yokoyama A, Olsson J, Gray S, Holweg CT, Eisner M, Asare C, Fischer SK, Peng K, Putnam WS, Matthews JG. Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials. Lancet Respir Med. 2016 10; 4(10):781-796. PMID: 27616196.
      Citations: 110     Fields:    Translation:HumansCellsCTClinical Trials
    178. Lambert AA, Putcha N, Drummond MB, Boriek AM, Hanania NA, Kim V, Kinney GL, McDonald MN, Brigham EP, Wise RA, McCormack MC, Hansel NN, COPDGene Investigators. Obesity Is Associated With Increased Morbidity in Moderate to Severe COPD. Chest. 2017 Jan; 151(1):68-77. PMID: 27568229; PMCID: PMC5310126.
      Citations: 52     Fields:    Translation:Humans
    179. Sun W, Kechris K, Jacobson S, Drummond MB, Hawkins GA, Yang J, Chen TH, Quibrera PM, Anderson W, Barr RG, Basta PV, Bleecker ER, Beaty T, Casaburi R, Castaldi P, Cho MH, Comellas A, Crapo JD, Criner G, Demeo D, Christenson SA, Couper DJ, Curtis JL, Doerschuk CM, Freeman CM, Gouskova NA, Han MK, Hanania NA, Hansel NN, Hersh CP, Hoffman EA, Kaner RJ, Kanner RE, Kleerup EC, Lutz S, Martinez FJ, Meyers DA, Peters SP, Regan EA, Rennard SI, Scholand MB, Silverman EK, Woodruff PG, O'Neal WK, Bowler RP, SPIROMICS Research Group, COPDGene Investigators. Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD. PLoS Genet. 2016 Aug; 12(8):e1006011. PMID: 27532455; PMCID: PMC4988780.
      Citations: 50     Fields:    Translation:Humans
    180. Herscher ML, Wisnivesky JP, Busse PJ, Hanania NA, Sheng T, Wolf MS, Federman AD. Characteristics and outcomes of older adults with long-standing versus late-onset asthma. J Asthma. 2017 04; 54(3):223-229. PMID: 27459257.
      Citations: 7     Fields:    Translation:Humans
    181. Kim V, Zhao H, Boriek AM, Anzueto A, Soler X, Bhatt SP, Rennard SI, Wise R, Comellas A, Ramsdell JW, Kinney GL, Han MK, Martinez CH, Yen A, Black-Shinn J, Porszasz J, Criner GJ, Hanania NA, Sharafkhaneh A, Crapo JD, Make BJ, Silverman EK, Curtis JL, COPDGene Investigators. Persistent and Newly Developed Chronic Bronchitis Are Associated with Worse Outcomes in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2016 07; 13(7):1016-25. PMID: 27158740; PMCID: PMC5015750.
      Citations: 22     Fields:    Translation:Humans
    182. Banerji D, Mahler DA, Hanania NA. Efficacy and safety of LABA/LAMA fixed-dose combinations approved in the US for the management of COPD. Expert Rev Respir Med. 2016 07; 10(7):767-80. PMID: 27223863.
      Citations: 2     Fields:    Translation:Humans
    183. Bujarski S, Parulekar AD, Hanania NA. Lebrikizumab in the treatment of asthma. Expert Opin Biol Ther. 2016; 16(6):847-852. PMID: 27161908.
      Citations: 3     Fields:    
    184. Buhl R, Korn S, Menzies-Gow A, Chapman KR, Canonica GW, Martin N, Escobar RA, Korom S, Hanania NA, Aubier M, Picado C. Assessing biomarkers in a real-world severe asthma study (ARIETTA). Respir Med. 2016 06; 115:7-12. PMID: 27215497.
      Citations: 5     Fields:    Translation:HumansCellsCTClinical Trials
    185. Yohannes AM, Dryden S, Hanania NA. The Responsiveness of the Anxiety Inventory for Respiratory Disease Scale Following Pulmonary Rehabilitation. Chest. 2016 07; 150(1):188-95. PMID: 26953219.
      Citations: 5     Fields:    Translation:Humans
    186. Yohannes AM, Hanania NA, Lavoie K, Tal-Singer R, Vestbo J, Rennard SI, Wouters EF, M?llerov? H. Long-term Course of Depression Trajectories in Patients With COPD: A 3-Year Follow-up Analysis of the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints Cohort. Chest. 2016 Apr; 149(4):916-26. PMID: 26836938.
      Citations: 12     Fields:    Translation:Humans
    187. Hanania NA, Diamant Z. Editorial: The new look on asthma: linking phenotypes, endotypes and biomarkers to asthma management. Curr Opin Pulm Med. 2016 Jan; 22(1):1-2. PMID: 26574722.
      Citations: 1     Fields:    
    188. Diamant Z, Hanania NA, Parulekar AD. Role of T2 inflammation biomarkers in severe asthma. Curr Opin Pulm Med. 2016 Jan; 22(1):59-68. PMID: 26574724.
      Citations: 23     Fields:    Translation:HumansCells
    189. Martinez CH, Diaz AA, Parulekar AD, Rennard SI, Kanner RE, Hansel NN, Couper D, Holm KE, Hoth KF, Curtis JL, Martinez FJ, Hanania NA, Regan EA, Paine R, Cigolle CT, Han MK, COPDGene and SPIROMICS Investigators. Age-Related Differences in Health-Related Quality of Life in COPD: An Analysis of the COPDGene and SPIROMICS Cohorts. Chest. 2016 Apr; 149(4):927-35. PMID: 26836895; PMCID: PMC4944781.
      Citations: 9     Fields:    Translation:Humans
    190. Checkley W, Foreman MG, Bhatt SP, Dransfield MT, Han M, Hanania NA, Hansel NN, Regan EA, Wise RA, COPDGene Study Investigators. Differences between absolute and predicted values of forced expiratory volumes to classify ventilatory impairment in chronic obstructive pulmonary disease. Respir Med. 2016 Feb; 111:30-8. PMID: 26712569; PMCID: PMC4955626.
      Citations: 3     Fields:    Translation:Humans
    191. Douglas IS, Albertson TE, Folan P, Hanania NA, Tashkin DP, Upson DJ, Leone FT. Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup. Ann Am Thorac Soc. 2015 Nov; 12(11):1700-10. PMID: 26540421.
      Citations: 2     Fields:    Translation:HumansAnimals
    192. Djukanovic R, Hanania N, Busse W, Price D. IgE-mediated asthma: New revelations and future insights. Respir Med. 2016 Mar; 112:128-9. PMID: 26577335.
      Citations: 4     Fields:    Translation:Humans
    193. Hanania NA, Noonan M, Corren J, Korenblat P, Zheng Y, Fischer SK, Cheu M, Putnam WS, Murray E, Scheerens H, Holweg CT, Maciuca R, Gray S, Doyle R, McClintock D, Olsson J, Matthews JG, Yen K. Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies. Thorax. 2015 Aug; 70(8):748-56. PMID: 26001563; PMCID: PMC4515999.
      Citations: 105     Fields:    Translation:Humans
    194. Cazzola M, Hanania NA, MacNee W, Hackford C, Tamimi N, R?dell K. A review of the most common patient-reported outcomes in COPD--revisiting current knowledge and estimating future challenges. Int J Chron Obstruct Pulmon Dis. 2015; 10:725-38. PMID: 25897216; PMCID: PMC4396518.
      Citations: 17     Fields:    Translation:Humans
    195. Criner GJ, Bourbeau J, Diekemper RL, Ouellette DR, Goodridge D, Hernandez P, Curren K, Balter MS, Bhutani M, Camp PG, Celli BR, Dechman G, Dransfield MT, Fiel SB, Foreman MG, Hanania NA, Ireland BK, Marchetti N, Marciniuk DD, Mularski RA, Ornelas J, Road JD, Stickland MK. Executive summary: prevention of acute exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest. 2015 Apr; 147(4):883-893. PMID: 25320966; PMCID: PMC4388123.
      Citations: 20     Fields:    Translation:Humans
    196. Criner GJ, Bourbeau J, Diekemper RL, Ouellette DR, Goodridge D, Hernandez P, Curren K, Balter MS, Bhutani M, Camp PG, Celli BR, Dechman G, Dransfield MT, Fiel SB, Foreman MG, Hanania NA, Ireland BK, Marchetti N, Marciniuk DD, Mularski RA, Ornelas J, Road JD, Stickland MK. Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest. 2015 Apr; 147(4):894-942. PMID: 25321320; PMCID: PMC4388124.
      Citations: 85     Fields:    Translation:Humans
    197. Chow L, Parulekar AD, Hanania NA. Hospital management of acute exacerbations of chronic obstructive pulmonary disease. J Hosp Med. 2015 May; 10(5):328-39. PMID: 25820201.
      Citations: 6     Fields:    Translation:Humans
    198. Bujarski S, Parulekar AD, Sharafkhaneh A, Hanania NA. The asthma COPD overlap syndrome (ACOS). Curr Allergy Asthma Rep. 2015 Mar; 15(3):509. PMID: 25712010.
      Citations: 23     Fields:    Translation:Humans
    199. Crim C, Dransfield MT, Bourbeau J, Jones PW, Hanania NA, Mahler DA, Wachtel A, Martinez FJ, Barnhart F, Lettis S, Calverley PM, Vestbo J. Pneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPD. Ann Am Thorac Soc. 2015 Jan; 12(1):27-34. PMID: 25490706.
      Citations: 47     Fields:    Translation:Humans
    200. Diamant Z, Hanania NA, Parulekar AD. Antifungals in severe asthma. Curr Opin Pulm Med. 2015 Jan; 21(1):48-54. PMID: 25415408.
      Citations: 9     Fields:    Translation:HumansAnimals
    201. Rogers L, Hanania NA. Role of anticholinergics in asthma management: recent evidence and future needs. Curr Opin Pulm Med. 2015 Jan; 21(1):103-8. PMID: 25415409.
      Citations: 1     Fields:    Translation:Humans
    202. Putcha N, Puhan MA, Drummond MB, Han MK, Regan EA, Hanania NA, Martinez CH, Foreman M, Bhatt SP, Make B, Ramsdell J, DeMeo DL, Barr RG, Rennard SI, Martinez F, Silverman EK, Crapo J, Wise RA, Hansel NN. A simplified score to quantify comorbidity in COPD. PLoS One. 2014; 9(12):e114438. PMID: 25514500; PMCID: PMC4267736.
      Citations: 36     Fields:    Translation:Humans
    203. Donohue JF, Hanania NA, Make B, Miles MC, Mahler DA, Curry L, Tosiello R, Wheeler A, Tashkin DP. One-year safety and efficacy study of arformoterol tartrate in patients with moderate to severe COPD. Chest. 2014 Dec; 146(6):1531-1542. PMID: 25451347; PMCID: PMC4251615.
      Citations: 10     Fields:    Translation:Humans
    204. Qureshi H, Sharafkhaneh A, Hanania NA. Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications. Ther Adv Chronic Dis. 2014 Sep; 5(5):212-27. PMID: 25177479; PMCID: PMC4131503.
      Citations: 49     
    205. Sharafkhaneh A, Altan AE, Colice GL, Hanania NA, Donohue JF, Kurlander JL, Rodriguez-Roisin R, Altman PR. A simple rule to identify patients with chronic obstructive pulmonary disease who may need treatment reevaluation. Respir Med. 2014 Sep; 108(9):1310-20. PMID: 25130680.
      Citations: 4     Fields:    Translation:Humans
    206. Busse W, Hanania NA, Lowe PJ, Canvin J, Erpenbeck VJ, Holgate S, Humbert M. Omalizumab in asthma: an update on recent developments. J Allergy Clin Immunol Pract. 2014 Sep-Oct; 2(5):525-36.e1. PMID: 25213045.
      Citations: 50     Fields:    Translation:Humans
    207. Hanania NA. The Saudi guidelines for chronic obstructive pulmonary disease: A fresh "Real-World" approach to COPD. Ann Thorac Med. 2014 Apr; 9(2):53-4. PMID: 24791167; PMCID: PMC4005163.
      Citations:    
    208. Koshy S, Huq R, Tanner MR, Atik MA, Porter PC, Khan FS, Pennington MW, Hanania NA, Corry DB, Beeton C. Blocking KV1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthma. J Biol Chem. 2014 May 02; 289(18):12623-32. PMID: 24644290; PMCID: PMC4007452.
      Citations: 30     Fields:    Translation:HumansAnimalsCells
    209. Parulekar AD, Atik MA, Hanania NA. Periostin, a novel biomarker of TH2-driven asthma. Curr Opin Pulm Med. 2014 Jan; 20(1):60-5. PMID: 24247042.
      Citations: 44     Fields:    Translation:HumansCells
    210. Putcha N, Han MK, Martinez CH, Foreman MG, Anzueto AR, Casaburi R, Cho MH, Hanania NA, Hersh CP, Kinney GL, Make BJ, Steiner RM, Lutz SM, Thomashow BM, Williams AA, Bhatt SP, Beaty TH, Bowler RP, Ramsdell JW, Curtis JL, Everett D, Hokanson JE, Lynch DA, Sutherland ER, Silverman EK, Crapo JD, Wise RA, Regan EA, Hansel NN, the COPDGene? Investigators. Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans. Chronic Obstr Pulm Dis. 2014; 1(1):105-114. PMID: 25695106; PMCID: PMC4329763.
      Citations: 21     
    211. Hanania NA. Evaluating the safety of COPD medications: an evidence-based review. Chest. 2013 Oct; 144(4):1357-1367. PMID: 24081347.
      Citations: 1     Fields:    Translation:Humans
    212. Hanania NA, Calverley PM, Dransfield MT, Karpel JP, Zhu H, Rowe P, Brose M, Goehring UM. Pooled subpopulation analyses of the effects of roflumilast on exacerbations and lung function in COPD. Respir Med. 2014 Feb; 108(2):366-75. PMID: 24120253.
      Citations: 13     Fields:    Translation:Humans
    213. Wechsler ME, Laviolette M, Rubin AS, Fiterman J, Lapa e Silva JR, Shah PL, Fiss E, Olivenstein R, Thomson NC, Niven RM, Pavord ID, Simoff M, Hales JB, McEvoy C, Slebos DJ, Holmes M, Phillips MJ, Erzurum SC, Hanania NA, Sumino K, Kraft M, Cox G, Sterman DH, Hogarth K, Kline JN, Mansur AH, Louie BE, Leeds WM, Barbers RG, Austin JH, Shargill NS, Quiring J, Armstrong B, Castro M, Asthma Intervention Research 2 Trial Study Group. Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma. J Allergy Clin Immunol. 2013 Dec; 132(6):1295-302. PMID: 23998657; PMCID: PMC4114404.
      Citations: 69     Fields:    Translation:Humans
    214. Hanania NA, Wenzel S, Hsieh HJ, Mosesova S, Choy DF, Lal P, Arron JR, Harris JM, Busse W, Ros?n K. Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study. Am J Respir Crit Care Med. 2013 Apr 15; 187(8):804-11. PMID: 23471469.
      Citations: 197     Fields:    Translation:HumansCells
    215. Dransfield MT, Bourbeau J, Jones PW, Hanania NA, Mahler DA, Wachtel A, Martinez FJ, Barnhart F, Sanford L, Lettis S, Crim C, Calverley PM, Vestbo J. Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials. Lancet Respir Med. 2013 May; 1(3):210-23. PMID: 24429127.
      Citations: 110     Fields:    Translation:Humans
    216. Sharafkhaneh A, Wolf RA, Goodnight S, Hanania NA, Make BJ, Tashkin DP. Perceptions and attitudes toward the use of nebulized therapy for COPD: patient and caregiver perspectives. COPD. 2013 Aug; 10(4):482-92. PMID: 23875742.
      Citations: 15     Fields:    Translation:Humans
    217. Yohannes AM, Connolly MJ, Hanania NA. Ten years of tiotropium: clinical impact and patient perspectives. Int J Chron Obstruct Pulmon Dis. 2013; 8:117-25. PMID: 23515335; PMCID: PMC3600941.
      Citations: 12     Fields:    Translation:Humans
    218. Spencer P, Hanania NA. Optimizing safety of COPD treatments: role of the nurse practitioner. J Multidiscip Healthc. 2013; 6:53-63. PMID: 23459224; PMCID: PMC3583441.
      Citations: 6     
    219. Tsai CL, Lee WY, Delclos GL, Hanania NA, Camargo CA. Comparative effectiveness of noninvasive ventilation vs invasive mechanical ventilation in chronic obstructive pulmonary disease patients with acute respiratory failure. J Hosp Med. 2013 Apr; 8(4):165-72. PMID: 23401469.
      Citations: 15     Fields:    Translation:Humans
    220. Tsai CL, Delclos GL, Huang JS, Hanania NA, Camargo CA. Age-related differences in asthma outcomes in the United States, 1988-2006. Ann Allergy Asthma Immunol. 2013 Apr; 110(4):240-6, 246.e1. PMID: 23535086.
      Citations: 15     Fields:    Translation:Humans
    221. Hansel NN, Washko GR, Foreman MG, Han MK, Hoffman EA, DeMeo DL, Barr RG, Van Beek EJ, Kazerooni EA, Wise RA, Brown RH, Black-Shinn J, Hokanson JE, Hanania NA, Make B, Silverman EK, Crapo JD, Dransfield MT, COPDGene Investigators. Racial differences in CT phenotypes in COPD. COPD. 2013 Feb; 10(1):20-7. PMID: 23413893; PMCID: PMC4321889.
      Citations: 20     Fields:    Translation:HumansCTClinical Trials
    222. Decramer ML, Hanania NA, Yawn BP, L?tvall JO. The safety of long-acting ?2-agonists in the treatment of stable chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2013; 8:53-64. PMID: 23378756; PMCID: PMC3558319.
      Citations: 17     Fields:    Translation:Humans
    223. Parulekar AD, Alobaidy A, Hanania NA. Asthma outcomes revisited. Curr Opin Pulm Med. 2013 Jan; 19(1):6-12. PMID: 23196270.
      Citations: 2     Fields:    Translation:Humans
    224. Hanania NA. Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. Respir Med. 2012 Dec; 106 Suppl 2:S1-2. PMID: 23290699.
      Citations: 1     Fields:    Translation:Humans
    225. Adams SG, Pitts J, Wynne J, Yawn BP, Diamond EJ, Lee S, Dellert E, Hanania NA. Effect of a primary care continuing education program on clinical practice of chronic obstructive pulmonary disease: translating theory into practice. Mayo Clin Proc. 2012 Sep; 87(9):862-70. PMID: 22958990; PMCID: PMC3538496.
      Citations: 12     Fields:    Translation:Humans
    226. Al-shair K, Muellerova H, Yorke J, Rennard SI, Wouters EF, Hanania NA, Sharafkhaneh A, ECLIPSE investigators, Vestbo J. Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale. Health Qual Life Outcomes. 2012 Aug 23; 10:100. PMID: 22913289; PMCID: PMC3491053.
      Citations: 12     Fields:    Translation:Humans
    227. Hanania NA, Feldman G, Zachgo W, Shim JJ, Crim C, Sanford L, Lettis S, Barnhart F, Haumann B. The efficacy and safety of the novel long-acting ?2 agonist vilanterol in patients with COPD: a randomized placebo-controlled trial. Chest. 2012 Jul; 142(1):119-127. PMID: 22241764.
      Citations: 27     Fields:    Translation:Humans
    228. Mak G, Hanania NA. New bronchodilators. Curr Opin Pharmacol. 2012 Jun; 12(3):238-45. PMID: 22445544.
      Citations: 8     Fields:    Translation:HumansAnimals
    229. COPDGene CT Workshop Group, Barr RG, Berkowitz EA, Bigazzi F, Bode F, Bon J, Bowler RP, Chiles C, Crapo JD, Criner GJ, Curtis JL, Dass C, Dirksen A, Dransfield MT, Edula G, Erikkson L, Friedlander A, Galperin-Aizenberg M, Gefter WB, Gierada DS, Grenier PA, Goldin J, Han MK, Hanania NA, Hansel NN, Jacobson FL, Kauczor HU, Kinnula VL, Lipson DA, Lynch DA, MacNee W, Make BJ, Mamary AJ, Mann H, Marchetti N, Mascalchi M, McLennan G, Murphy JR, Naidich D, Nath H, Newell JD, Pistolesi M, Regan EA, Reilly JJ, Sandhaus R, Schroeder JD, Sciurba F, Shaker S, Sharafkhaneh A, Silverman EK, Steiner RM, Strange C, Sverzellati N, Tashjian JH, van Beek EJ, Washington L, Washko GR, Westney G, Wood SA, Woodruff PG. A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD. 2012 Apr; 9(2):151-9. PMID: 22429093; PMCID: PMC3752926.
      Citations: 73     Fields:    Translation:Humans
    230. Tsai CL, Lee WY, Hanania NA, Camargo CA. Age-related differences in clinical outcomes for acute asthma in the United States, 2006-2008. J Allergy Clin Immunol. 2012 May; 129(5):1252-1258.e1. PMID: 22385630.
      Citations: 52     Fields:    Translation:Humans
    231. Kuhl K, Hanania NA. Targeting IgE in asthma. Curr Opin Pulm Med. 2012 Jan; 18(1):1-5. PMID: 22139745.
      Citations: 16     Fields:    Translation:Humans
    232. Tamimi A, Serdarevic D, Hanania NA. The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications. Respir Med. 2012 Mar; 106(3):319-28. PMID: 22196881.
      Citations: 69     Fields:    Translation:Humans
    233. Hanania NA, Crater GD, Morris AN, Emmett AH, O'Dell DM, Niewoehner DE. Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD. Respir Med. 2012 Jan; 106(1):91-101. PMID: 22040533.
      Citations: 31     Fields:    Translation:Humans
    234. Kao CC, Hsu JW, Bandi V, Hanania NA, Kheradmand F, Jahoor F. Glucose and pyruvate metabolism in severe chronic obstructive pulmonary disease. J Appl Physiol (1985). 2012 Jan; 112(1):42-7. PMID: 22016370; PMCID: PMC3290418.
      Citations: 14     Fields:    Translation:HumansCells
    235. Hanania NA, Celli BR, Donohue JF, Martin UJ. Bronchodilator reversibility in COPD. Chest. 2011 Oct; 140(4):1055-1063. PMID: 21972384.
      Citations: 30     Fields:    Translation:Humans
    236. Dalal AA, Shah M, Lunacsek O, Hanania NA. Clinical and economic burden of patients diagnosed with COPD with comorbid cardiovascular disease. Respir Med. 2011 Oct; 105(10):1516-22. PMID: 21684731.
      Citations: 31     Fields:    Translation:Humans
    237. Gross NJ, Hanania NA. The COPD Pipeline XII. COPD. 2011 Oct; 8(5):387-91. PMID: 21905763.
      Citations:    Fields:    Translation:Humans
    238. Hanania NA, King MJ, Braman SS, Saltoun C, Wise RA, Enright P, Falsey AR, Mathur SK, Ramsdell JW, Rogers L, Stempel DA, Lima JJ, Fish JE, Wilson SR, Boyd C, Patel KV, Irvin CG, Yawn BP, Halm EA, Wasserman SI, Sands MF, Ershler WB, Ledford DK, Asthma in Elderly workshop participants. Asthma in the elderly: Current understanding and future research needs--a report of a National Institute on Aging (NIA) workshop. J Allergy Clin Immunol. 2011 Sep; 128(3 Suppl):S4-24. PMID: 21872730; PMCID: PMC3164961.
      Citations: 68     Fields:    Translation:HumansPHPublic Health
    239. Hanania NA, Marciniuk DD. A unified front against COPD: clinical practice guidelines from the American College of Physicians, the American College of Chest Physicians, the American Thoracic Society, and the European Respiratory Society. Chest. 2011 Sep; 140(3):565-566. PMID: 21896511.
      Citations: 11     Fields:    Translation:Humans
    240. Dalal AA, Shah M, Lunacsek O, Hanania NA. Clinical and economic burden of depression/anxiety in chronic obstructive pulmonary disease patients within a managed care population. COPD. 2011 Aug; 8(4):293-9. PMID: 21827298.
      Citations: 34     Fields:    Translation:Humans
    241. Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR, Harris JM, Scheerens H, Wu LC, Su Z, Mosesova S, Eisner MD, Bohen SP, Matthews JG. Lebrikizumab treatment in adults with asthma. N Engl J Med. 2011 Sep 22; 365(12):1088-98. PMID: 21812663.
      Citations: 482     Fields:    Translation:Humans
    242. Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, Wedzicha W, MacDonald R, Shekelle P, American College of Physicians, American College of Chest Physicians, American Thoracic Society, European Respiratory Society, Sch?nemann H. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011 Aug 02; 155(3):179-91. PMID: 21810710.
      Citations: 363     Fields:    Translation:Humans
    243. Han MK, Kazerooni EA, Lynch DA, Liu LX, Murray S, Curtis JL, Criner GJ, Kim V, Bowler RP, Hanania NA, Anzueto AR, Make BJ, Hokanson JE, Crapo JD, Silverman EK, Martinez FJ, Washko GR, COPDGene Investigators. Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology. 2011 Oct; 261(1):274-82. PMID: 21788524; PMCID: PMC3184233.
      Citations: 170     Fields:    Translation:Humans
    244. Kim YI, Schroeder J, Lynch D, Newell J, Make B, Friedlander A, Hanania NA, Washko G, Murphy JR, Wilson C, Hokanson JE, Zach J, Butterfield K, Bowler RP, Est?par RS. Gender differences of airway dimensions in anatomically matched sites on CT in smokers. COPD. 2011 Aug; 8(4):285-92. PMID: 21756032; PMCID: PMC3703311.
      Citations: 18     Fields:    Translation:Humans
    245. Han MK, Curran-Everett D, Dransfield MT, Criner GJ, Zhang L, Murphy JR, Hansel NN, DeMeo DL, Hanania NA, Regan EA, Make BJ, Martinez FJ, Westney GE, Foreman MG, COPDGene Investigators. Racial differences in quality of life in patients with COPD. Chest. 2011 Nov; 140(5):1169-1176. PMID: 21636665; PMCID: PMC3205846.
      Citations: 27     Fields:    Translation:Humans
    246. Drexel C, Jacobson A, Hanania NA, Whitfield B, Katz J, Sullivan T. Measuring the impact of a live, case-based, multiformat, interactive continuing medical education program on improving clinician knowledge and competency in evidence-based COPD care. Int J Chron Obstruct Pulmon Dis. 2011; 6:297-307. PMID: 21697994; PMCID: PMC3119105.
      Citations: 12     Fields:    Translation:Humans
    247. Kao CC, Hsu JW, Bandi V, Hanania NA, Kheradmand F, Jahoor F. Resting energy expenditure and protein turnover are increased in patients with severe chronic obstructive pulmonary disease. Metabolism. 2011 Oct; 60(10):1449-55. PMID: 21550084; PMCID: PMC3176951.
      Citations: 15     Fields:    Translation:HumansCells
    248. Hanania NA, Alpan O, Hamilos DL, Condemi JJ, Reyes-Rivera I, Zhu J, Rosen KE, Eisner MD, Wong DA, Busse W. Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial. Ann Intern Med. 2011 05 03; 154(9):573-82. PMID: 21536936.
      Citations: 133     Fields:    Translation:Humans
    249. Mintz ML, Yawn BP, Mannino DM, Donohue JF, Hanania NA, Grellet CA, Gilsenan AW, McLeod LD, Dalal AA, Raphiou IH, Prillaman BA, Crater GD, Cicale MJ, Mapel DW. Prevalence of airway obstruction assessed by lung function questionnaire. Mayo Clin Proc. 2011 May; 86(5):375-81. PMID: 21531880; PMCID: PMC3084639.
      Citations: 10     Fields:    Translation:Humans
    250. Hanania NA. Safety of chronic obstructive pulmonary disease medications: a primary care perspective. Postgrad Med. 2011 May; 123(3):72-9. PMID: 21566417.
      Citations:    Fields:    Translation:Humans
    251. Walker JK, Penn RB, Hanania NA, Dickey BF, Bond RA. New perspectives regarding ?(2) -adrenoceptor ligands in the treatment of asthma. Br J Pharmacol. 2011 May; 163(1):18-28. PMID: 21175591; PMCID: PMC3085865.
      Citations: 51     Fields:    Translation:HumansAnimalsCells
    252. Castro M, Rubin A, Laviolette M, Hanania NA, Armstrong B, Cox G, AIR2 Trial Study Group. Persistence of effectiveness of bronchial thermoplasty in patients with severe asthma. Ann Allergy Asthma Immunol. 2011 Jul; 107(1):65-70. PMID: 21704887.
      Citations: 27     Fields:    Translation:Humans
    253. Hanania NA, Sharafkhaneh A, Celli B, Decramer M, Lystig T, Kesten S, Tashkin D. Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial. Respir Res. 2011 Jan 11; 12:6. PMID: 21219660; PMCID: PMC3027109.
      Citations: 18     Fields:    Translation:Humans
    254. Mak G, Hanania NA. Vitamin D and asthma. Curr Opin Pulm Med. 2011 Jan; 17(1):1-5. PMID: 21045696.
      Citations: 10     Fields:    Translation:Humans
    255. Hanania NA, Sharma G, Sharafkhaneh A. COPD in the elderly patient. Semin Respir Crit Care Med. 2010 Oct; 31(5):596-606. PMID: 20941660.
      Citations: 19     Fields:    Translation:Humans
    256. Sharafkhaneh A, Mattewal AS, Abraham VM, Dronavalli G, Hanania NA. Budesonide/formoterol combination in COPD: a US perspective. Int J Chron Obstruct Pulmon Dis. 2010 Oct 05; 5:357-66. PMID: 21037960; PMCID: PMC2962302.
      Citations: 13     Fields:    Translation:HumansAnimals
    257. Hanania NA, Mannava B, Franklin AE, Lipworth BJ, Williamson PA, Garner WJ, Dickey BF, Bond RA. Response to salbutamol in patients with mild asthma treated with nadolol. Eur Respir J. 2010 Oct; 36(4):963-5. PMID: 20889466.
      Citations: 18     Fields:    Translation:Humans
    258. Hanania NA, Locantore NW, Watkins ML, Wouters EF, Rennard SI, Sharafkhaneh A, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study investi, M?llerova H, Vestbo J. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med. 2011 Mar 01; 183(5):604-11. PMID: 20889909.
      Citations: 90     Fields:    Translation:Humans
    259. Dickey BF, Walker JK, Hanania NA, Bond RA. beta-Adrenoceptor inverse agonists in asthma. Curr Opin Pharmacol. 2010 Jun; 10(3):254-9. PMID: 20399707; PMCID: PMC2905467.
      Citations: 15     Fields:    Translation:HumansAnimalsCells
    260. Sharafkhaneh A, Petersen NJ, Yu HJ, Dalal AA, Johnson ML, Hanania NA. Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population. Int J Chron Obstruct Pulmon Dis. 2010 May 06; 5:125-32. PMID: 20461144; PMCID: PMC2866562.
      Citations: 20     Fields:    Translation:Humans
    261. Cazzola M, Hanania NA, Matera MG. Arformoterol tartrate in the treatment of COPD. Expert Rev Respir Med. 2010 Apr; 4(2):155-62. PMID: 20406080.
      Citations: 1     Fields:    Translation:Humans
    262. Hanania NA, Mannino DM, Yawn BP, Mapel DW, Martinez FJ, Donohue JF, Kosinski M, Rendas-Baum R, Mintz M, Samuels S, Jhingran P, Dalal AA. Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ). Respir Med. 2010 Aug; 104(8):1160-70. PMID: 20226647.
      Citations: 36     Fields:    Translation:Humans
    263. Yawn BP, Mapel DW, Mannino DM, Martinez FJ, Donohue JF, Hanania NA, Kosinski M, Rendas-Baum R, Mintz M, Samuels S, Dalal AA, Lung Function Questionnaire Working Group. Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction. Int J Chron Obstruct Pulmon Dis. 2010 Feb 18; 5:1-10. PMID: 20368906; PMCID: PMC2846155.
      Citations: 33     Fields:    Translation:HumansPHPublic Health
    264. Hanania NA, Donohue JF, Nelson H, Sciarappa K, Goodwin E, Baumgartner RA, Hanrahan JP. The safety and efficacy of arformoterol and formoterol in COPD. COPD. 2010 Feb; 7(1):17-31. PMID: 20214460.
      Citations: 7     Fields:    Translation:HumansCells
    265. Cully JA, Stanley MA, Deswal A, Hanania NA, Phillips LL, Kunik ME. Cognitive-behavioral therapy for chronic cardiopulmonary conditions: preliminary outcomes from an open trial. Prim Care Companion J Clin Psychiatry. 2010; 12(4). PMID: 21085552; PMCID: PMC2983462.
      Citations: 18     
    266. King MJ, Hanania NA. Asthma in the elderly: current knowledge and future directions. Curr Opin Pulm Med. 2010 Jan; 16(1):55-9. PMID: 19844181.
      Citations: 10     Fields:    Translation:Humans
    267. Hanania NA, Dickey BF, Bond RA. Clinical implications of the intrinsic efficacy of beta-adrenoceptor drugs in asthma: full, partial and inverse agonism. Curr Opin Pulm Med. 2010 Jan; 16(1):1-5. PMID: 19887938; PMCID: PMC2855430.
      Citations: 13     Fields:    Translation:Humans
    268. Tashkin DP, Hanania NA, McGinty J, Denis-Mize K, Chaudry I. Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease. Adv Ther. 2009 Nov; 26(11):1024-34. PMID: 19953349.
      Citations: 3     Fields:    Translation:Humans
    269. Sharma G, Hanania NA, Shim YM. The aging immune system and its relationship to the development of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2009 Dec 01; 6(7):573-80. PMID: 19934352; PMCID: PMC5820858.
      Citations: 41     Fields:    Translation:Humans
    270. Bailey WC, Sciurba FC, Hanania NA, Donohue JF, Ferguson GT, Zibrak JD, Sharafkhaneh A, Marcus P, Rosa K, Piault EC, Martinez FJ. Development and validation of the Chronic Obstructive Pulmonary Disease Assessment Questionnaire (COPD-AQ). Prim Care Respir J. 2009 Sep; 18(3):198-207. PMID: 19492178; PMCID: PMC6619264.
      Citations: 5     Fields:    Translation:Humans
    271. Hanania NA, Boota A, Kerwin E, Tomlinson L, Denis-Mize K. Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial. Drugs. 2009 Jun 18; 69(9):1205-16. PMID: 19537837.
      Citations: 12     Fields:    Translation:Humans
    272. Nguyen LP, Lin R, Parra S, Omoluabi O, Hanania NA, Tuvim MJ, Knoll BJ, Dickey BF, Bond RA. Beta2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine model. Proc Natl Acad Sci U S A. 2009 Feb 17; 106(7):2435-40. PMID: 19171883; PMCID: PMC2650174.
      Citations: 58     Fields:    Translation:HumansAnimalsCells
    273. Hanania NA. Asthma control: a new perspective on the management of asthma. Curr Opin Pulm Med. 2009 Jan; 15(1):1-3. PMID: 19077698.
      Citations:    Fields:    Translation:Humans
    274. Guntupalli KK, Reddy RM, Loutfi RH, Alapat PM, Bandi VD, Hanania NA. Evaluation of obstructive lung disease with vibration response imaging. J Asthma. 2008 Dec; 45(10):923-30. PMID: 19085584.
      Citations: 7     Fields:    Translation:Humans
    275. Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, Hanania NA, ACCP Workshop Panel on Anxiety and Depression in COPD. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008 Oct; 134(4 Suppl):43S-56S. PMID: 18842932; PMCID: PMC2849676.
      Citations: 202     Fields:    Translation:Humans
    276. Donohue JF, Hanania NA, Fogarty C, Campbell SC, Rinehart M, Denis-Mize K. Long-term safety of nebulized formoterol: results of a twelve-month open-label clinical trial. Ther Adv Respir Dis. 2008 Aug; 2(4):199-208. PMID: 19124372.
      Citations: 6     Fields:    Translation:Humans
    277. Cazzola M, Hanania NA, Jones PW, Mahler DA, Make B, Ohar J, Rennard S. It's about time--directing our attention toward modifying the course of COPD. Respir Med. 2008 Jun; 102 Suppl 1:S37-48. PMID: 18582796.
      Citations: 1     Fields:    Translation:Humans
    278. Sharafkhaneh A, Hanania NA, Kim V. Pathogenesis of emphysema: from the bench to the bedside. Proc Am Thorac Soc. 2008 May 01; 5(4):475-7. PMID: 18453358; PMCID: PMC2645322.
      Citations: 73     Fields:    Translation:HumansAnimals
    279. Donohue JF, Hanania NA, Sciarappa KA, Goodwin E, Grogan DR, Baumgartner RA, Hanrahan JP. Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance. Ther Adv Respir Dis. 2008 Apr; 2(2):37-48. PMID: 19124357.
      Citations: 12     Fields:    Translation:Humans
    280. Hanania NA. Targeting airway inflammation in asthma: current and future therapies. Chest. 2008 Apr; 133(4):989-98. PMID: 18398119.
      Citations: 20     Fields:    Translation:Humans
    281. Hanrahan JP, Hanania NA, Calhoun WJ, Sahn SA, Sciarappa K, Baumgartner RA. Effect of nebulized arformoterol on airway function in COPD: results from two randomized trials. COPD. 2008 Feb; 5(1):25-34. PMID: 18259972.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    282. Hanania NA. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD. Pulm Pharmacol Ther. 2008; 21(3):540-50. PMID: 18280761.
      Citations: 12     Fields:    Translation:Humans
    283. Donohue JF, Hanania NA, Ciubotaru RL, Noe L, Pasta DJ, Schaefer K, Claus R, Andrews WT, Roach J. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study. Clin Ther. 2008; 30 Spec No:989-1002. PMID: 18640474.
      Citations: 4     Fields:    Translation:Humans
    284. Sharafkhaneh A, Velamuri S, Badmaev V, Lan C, Hanania N. The potential role of natural agents in treatment of airway inflammation. Ther Adv Respir Dis. 2007 Dec; 1(2):105-20. PMID: 19124352.
      Citations: 12     Fields:    Translation:HumansAnimals
    285. Braman SS, Hanania NA. Asthma in older adults. Clin Chest Med. 2007 Dec; 28(4):685-702, v. PMID: 17967288.
      Citations: 14     Fields:    Translation:Humans
    286. Hanania NA, Donohue JF. Pharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators. Proc Am Thorac Soc. 2007 Oct 01; 4(7):526-34. PMID: 17878465.
      Citations: 12     Fields:    Translation:Humans
    287. Hanania NA. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes. Clin Ther. 2007 Oct; 29(10):2121-33. PMID: 18042470.
      Citations: 2     Fields:    Translation:Humans
    288. Hanania NA, Sharafkhaneh A. Update on the pharmacologic therapy for chronic obstructive pulmonary disease. Clin Chest Med. 2007 Sep; 28(3):589-607, vi-vii. PMID: 17720046.
      Citations: 2     Fields:    Translation:Humans
    289. Hanania NA, Singh S, El-Wali R, Flashner M, Franklin AE, Garner WJ, Dickey BF, Parra S, Ruoss S, Shardonofsky F, O'Connor BJ, Page C, Bond RA. The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study. Pulm Pharmacol Ther. 2008; 21(1):134-41. PMID: 17703976; PMCID: PMC2254137.
      Citations: 53     Fields:    Translation:HumansCTClinical Trials
    290. Cazzola M, Donner CF, Hanania NA. One hundred years of chronic obstructive pulmonary disease (COPD). Respir Med. 2007 Jun; 101(6):1049-65. PMID: 17363238.
      Citations: 10     Fields:    Translation:Humans
    291. Rebbapragada V, Hanania NA. Can we predict depression in COPD? COPD. 2007 Mar; 4(1):3-4. PMID: 17364671.
      Citations: 2     Fields:    Translation:Humans
    292. Baumgartner RA, Hanania NA, Calhoun WJ, Sahn SA, Sciarappa K, Hanrahan JP. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial. Clin Ther. 2007 Feb; 29(2):261-78. PMID: 17472819.
      Citations: 21     Fields:    Translation:Humans
    293. McCoy K, Shade DM, Irvin CG, Mastronarde JG, Hanania NA, Castro M, Anthonisen NR, American Lung Association Asthma Clinical Research Centers. Predicting episodes of poor asthma control in treated patients with asthma. J Allergy Clin Immunol. 2006 Dec; 118(6):1226-33. PMID: 17157651.
      Citations: 25     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    294. Hanania NA, Moore RH, Zimmerman JL, Miller CT, Bag R, Sharafkhaneh A, Dickey BF. The role of intrinsic efficacy in determining response to a beta2-agonist in acute severe asthma. Respir Med. 2007 May; 101(5):1007-14. PMID: 17052901.
      Citations: 7     Fields:    Translation:Humans
    295. Moore RH, Millman EE, Godines V, Hanania NA, Tran TM, Peng H, Dickey BF, Knoll BJ, Clark RB. Salmeterol stimulation dissociates beta2-adrenergic receptor phosphorylation and internalization. Am J Respir Cell Mol Biol. 2007 Feb; 36(2):254-61. PMID: 16980556; PMCID: PMC1899312.
      Citations: 28     Fields:    Translation:HumansCells
    296. Hanania NA. Revisiting asthma control: how should it best be defined? Pulm Pharmacol Ther. 2007; 20(5):483-92. PMID: 16782375.
      Citations: 3     Fields:    Translation:Humans
    297. Nowak R, Emerman C, Hanrahan JP, Parsey MV, Hanania NA, Claus R, Schaefer K, Baumgartner RA, XOPENEX Acute Severe Asthma Study Group. A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults. Am J Emerg Med. 2006 May; 24(3):259-67. PMID: 16635694.
      Citations: 12     Fields:    Translation:Humans
    298. Hanania NA, Atmar RL, Castro M. Influenza vaccine in patients with asthma. Expert Rev Vaccines. 2006 Feb; 5(1):111-8. PMID: 16451113.
      Citations: 1     Fields:    Translation:Humans
    299. Cazzola M, Hanania NA. The role of combination therapy with corticosteroids and long-acting beta2-agonists in the prevention of exacerbations in COPD. Int J Chron Obstruct Pulmon Dis. 2006; 1(4):345-54. PMID: 18044091; PMCID: PMC2707808.
      Citations: 8     Fields:    Translation:Humans
    300. Hanania NA, Ambrosino N, Calverley P, Cazzola M, Donner CF, Make B. Treatments for COPD. Respir Med. 2005 Dec; 99 Suppl B:S28-40. PMID: 16239101.
      Citations: 2     Fields:    Translation:Humans
    301. Hanania NA, Belfort MA. Acute asthma in pregnancy. Crit Care Med. 2005 Oct; 33(10 Suppl):S319-24. PMID: 16215354.
      Citations: 10     Fields:    Translation:Humans
    302. Hanania NA. The challenge of differentiating asthma from chronic obstructive pulmonary disease. Manag Care. 2005 Jul; 14(7 Suppl Obstructie Lung):9-15; discussion 24-6. PMID: 18564559.
      Citations: 1     Fields:    Translation:Humans
    303. Make B, Hanania NA, ZuWallack R, Kalberg C, Emmett A, Brown CP, Knobil K. The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study. Clin Ther. 2005 May; 27(5):531-42. PMID: 15978302.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    304. Soto FJ, Hanania NA. Selective phosphodiesterase-4 inhibitors in chronic obstructive lung disease. Curr Opin Pulm Med. 2005 Mar; 11(2):129-34. PMID: 15699784.
      Citations: 15     Fields:    Translation:Humans
    305. Hanania NA, Kalberg C, Yates J, Emmett A, Horstman D, Knobil K. The bronchodilator response to salmeterol is maintained with regular, long-term use in patients with COPD. Pulm Pharmacol Ther. 2005; 18(1):19-22. PMID: 15607123.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    306. Guy ES, Kirumaki A, Hanania NA. Acute asthma in pregnancy. Crit Care Clin. 2004 Oct; 20(4):731-45, x. PMID: 15388199.
      Citations: 7     Fields:    Translation:Humans
    307. Hanania NA, Moore RH. Anti-inflammatory activities of beta2-agonists. Curr Drug Targets Inflamm Allergy. 2004 Sep; 3(3):271-7. PMID: 15379595.
      Citations: 13     Fields:    Translation:HumansAnimals
    308. Hanania NA, Sockrider M, Castro M, Holbrook JT, Tonascia J, Wise R, Atmar RL, American Lung Association Asthma Clinical Research Centers. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. J Allergy Clin Immunol. 2004 Apr; 113(4):717-24. PMID: 15100679.
      Citations: 47     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    309. Hanania NA, Darken P, Horstman D, Reisner C, Lee B, Davis S, Shah T. The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD. Chest. 2003 Sep; 124(3):834-43. PMID: 12970006.
      Citations: 95     Fields:    Translation:HumansCTClinical Trials
    310. Rodriguez W, Hanania N, Guy E, Guntupalli J. Pulmonary-renal syndromes in the intensive care unit. Crit Care Clin. 2002 Oct; 18(4):881-95, x. PMID: 12418445.
      Citations: 5     Fields:    Translation:Humans
    311. Hanania NA, Sharafkhaneh A, Barber R, Dickey BF. Beta-agonist intrinsic efficacy: measurement and clinical significance. Am J Respir Crit Care Med. 2002 May 15; 165(10):1353-8. PMID: 12016095.
      Citations: 25     Fields:    Translation:HumansAnimals
    312. Nasta SD, Carrum GM, Shahab I, Hanania NA, Udden MM. Regression of a plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy. Leuk Lymphoma. 2002 Feb; 43(2):423-6. PMID: 11999580.
      Citations: 25     Fields:    Translation:Humans
    313. Hanania NA, Zimmerman JL. Accidental hypothermia. Crit Care Clin. 1999 Apr; 15(2):235-49. PMID: 10331126.
      Citations: 15     Fields:    Translation:Humans
    314. Hanania NA, Pope C, Guntupalli KK. Acute respiratory distress syndrome. Inhaled nitric oxide. Respir Care Clin N Am. 1998 Dec; 4(4):695-709. PMID: 9881400.
      Citations:    Fields:    Translation:Humans
    315. Jain S, Hanania NA, Guntupalli KK. Ventilation of patients with asthma and obstructive lung disease. Crit Care Clin. 1998 Oct; 14(4):685-705. PMID: 9891633.
      Citations: 4     Fields:    Translation:Humans
    316. Zimmerman JL, Hanania NA. Vasodilators in mechanical ventilation. Crit Care Clin. 1998 Oct; 14(4):611-27. PMID: 9891630.
      Citations:    Fields:    Translation:Humans
    317. Hanania NA, Tarlo SM, Silverman F, Urch B, Senathirajah N, Zamel N, Corey P. Effect of exposure to low levels of ozone on the response to inhaled allergen in allergic asthmatic patients. Chest. 1998 Sep; 114(3):752-6. PMID: 9743162.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    318. Hanania NA, David-Wang A, Kesten S, Chapman KR. Factors associated with emergency department dependence of patients with asthma. Chest. 1997 Feb; 111(2):290-5. PMID: 9041971.
      Citations: 14     Fields:    Translation:Humans
    319. Rebuck DA, Hanania NA, D'Urzo AD, Chapman KR. The accuracy of a handheld portable spirometer. Chest. 1996 Jan; 109(1):152-7. PMID: 8549178.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    320. Hanania NA, Chapman KR, Sturtridge WC, Szalai JP, Kesten S. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol. 1995 Nov; 96(5 Pt 1):571-9. PMID: 7499672.
      Citations: 28     Fields:    Translation:Humans
    321. Kesten S, Chew R, Hanania NA. Health-care utilization after near-fatal asthma. Chest. 1995 Jun; 107(6):1564-9. PMID: 7781347.
      Citations: 1     Fields:    Translation:Humans
    322. Hanania NA, Chapman KR, Kesten S. Adverse effects of inhaled corticosteroids. Am J Med. 1995 Feb; 98(2):196-208. PMID: 7847437.
      Citations: 52     Fields:    Translation:Humans
    323. Hanania NA, Wittman R, Kesten S, Chapman KR. Medical personnel's knowledge of and ability to use inhaling devices. Metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. Chest. 1994 Jan; 105(1):111-6. PMID: 8275720.
      Citations: 50     Fields:    Translation:Humans
    324. Hanania N, Hoffstein V. Tuberculosis presenting with generalized lymphadenopathy, pulmonary infiltrates, and bone destruction in a young man. Arch Intern Med. 1993 May 24; 153(10):1265-7. PMID: 8494479.
      Citations: 2     Fields:    Translation:Humans
    HANANIA's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (645)
    Explore
    _
    Co-Authors (60)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _